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ABSTRACT 
 
 
During early pregnancy, the concerted actions of the maternal steroid hormones, estrogen 
and progesterone, promote a unique process known as decidualization, which involves extensive 
proliferation and differentiation of uterine stromal cells. The molecular pathways underlying this 
hormonally induced cellular transformation, an essential prerequisite for embryo implantation, 
are poorly understood. We previously identified the transcription factor C/EBPβ as a target of 
steroid hormone regulation in the uterus. The uteri of C/EBPβ–null mice failed to undergo 
decidualization, indicating a critical role of this transcription factor in this process. In the present 
study, analyses of C/EBPβ-null uteri revealed that C/EBPβ mediates the effects of steroid 
hormones during decidualization in the mouse by modulating the expression of multiple key cell 
cycle regulatory factors that control the G2-M transition of the proliferating uterine stromal cells. 
Utilizing a unique primary human endometrial stromal cell (HESC) culture system, in which the 
cells undergo proliferation and differentiation in response to serum and steroid hormone and 
cAMP signaling, respectively, my research uncovered that C/EBPβ controls the G1/S transition 
of the proliferating HESCs by regulating the expression of specific cell cycle regulators such as 
cyclin E and E2F1. My studies, using a siRNA strategy, revealed that C/EBPβ also plays an 
essential role in human stromal differentiation. We employed microarray analysis to establish 
that several factors, such as BMP2, Wnt4, IL11Ra, and STAT3, are downstream targets of 
C/EBPβ during differentiation of HESCs. Further analysis of IL11Ra-STAT3 signaling and 
identification of downstream targets of STAT3 suggested that this signal transducer is a critical 
mediator of the function of C/EBPβ, providing a novel link between C/EBPβ and cytokine 
signaling pathways that regulate endometrial functions during decidualization.  The knowledge 
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gained from this study provides a better understanding of the molecular mechanisms underlying 
the decidualization phase of implantation. This research also will help us decipher the underlying 
causes of infertility and recurrent loss of early pregnancy. 
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CHAPTER 1 
Introduction 
1.1 Introduction 
Steroid hormones estrogen and progesterone regulate uterine functions during early 
pregnancy 
The physiological functions of mammalian uterus are profoundly influenced by 
the concerted and timely actions of the ovarian steroid hormones, estrogen (E) and 
progesterone (P). During pregnancy, these hormones orchestrate the changes in the 
uterine epithelium that makes it competent to attach to the embryo to initiate the process 
of implantation (1-4). Following the initial attachment step, the trophoblast invades the 
endometrial stroma, which then undergoes extensive proliferation, differentiation and 
remodeling, a process known as decidualization. This leads to the formation of 
“decidua”, a unique and transient maternal tissue that helps maintain an environment 
conducive for the growth and development of the implanting embryo until the placenta is 
formed. Although it is well-documented that uterine competence for embryo 
implantation, and the formation and function of the decidua are greatly influenced by E 
and P, the molecular pathways involved in this hormonally-induced cellular 
transformation event remain poorly understood. Furthermore, it is becoming increasingly 
evident that perturbations in these pathways may lead to improper uterine receptivity, 
decidualization, and eventual infertility due to early pregnancy loss. There is, therefore, a 
need to explore these hormone-regulated pathways to gain a better understanding of the 
dysfunctions that result in female infertility. 
Although the details of the events leading to implantation vary in different 
species, the central roles played by E and P in controlling various phases of early 
pregnancy are common to many mammals (5). In mice, on days 1 and 2 of pregnancy, 
ovarian E released at ovulation induces luminal and glandular epithelial cell proliferation. 
On day 3, the rising level of progesterone from the newly formed corpora lutea shifts the 
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proliferation from the epithelium to the stroma and switches the uterine epithelium to 
differentiate and become receptive.  A transient surge of E on day 4 of pregnancy triggers 
the implantation process (5). Then a generalized uterine edema promotes the closure of 
the uterine lumen and facilitate close attachment between the trophectoderm of the 
blastocyst and the uterineepithelium (6). 
 
Figure 1.1 Trophoblast invasion into the uterine stroma during implantation. 
(Adapted from Medical Physiology by Walter Boron and Emile Boulpaep) 
In mice, the blastocyst reaches the uterus four days after fertilization (7;8). The 
attachment of the blastocyst to the uterine epithelium initiates the process of 
decidualization that involves differentiation of the fibroblastic endometrial stromal cells 
into morphologically distinct cells, termed decidual cells (9-14). These transformed cells 
show unique secretory and biosynthetic properties. This cellular differentiation, induced 
by P following a brief priming by E, is a prerequisite for successful implantation. 
Decidua is a transient tissue, which first develops at the time of blastocyst attachment on 
day 4.5 of pregnancy. During the next 3 days of gestation, the decidual cells proliferate 
and differentiate extensively, and then they start to undergo apoptosis. By the end of the 
invasive period (day 10.5), the decidua is regressed. A variety of functions have been 
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attributed to the decidua, such as providing nutrition to the embryo, being a source of 
hormones, growth factors and cytokines, serving an immunoregulatory role during 
pregnancy and regulating trophoblast invasion (9-14). Steroid-induced signaling 
molecules that participate in the formation and function of this tissue remain poorly 
understood. 
Role of E- and P- regulated pathways in implantation 
The mouse has served as an important animal model to study the regulation of 
uterine functions by E and P (5;15-17). The cellular actions of these hormones are 
mediated through intracellular estrogen receptor (ER) and progesterone receptor (PR) 
proteins, which are hormone-inducible transcription factors (18). Hormone-occupied ER 
or PR triggers the expression of specific gene networks in different cell types within the 
uterus and the products of these genes are thought to mediate the hormonal effects during 
the reproductive cycle and pregnancy. The heterogeneous cell types (luminal and 
glandular epithelium, stroma and myometrium) in the uterus respond differently to E and 
P.  In general, estrogen induces the proliferation of luminal and glandular epithelial cells, 
while progesterone stimulates the proliferation and differentiation of stromal cells and 
maintains the pregnancy.  
The development of mutant mouse models lacking the estrogen receptor α (ERα) 
and progesterone receptor (PR) has firmly established the requirement of these hormones 
and their downstream signaling pathways for successful establishment and maintenance 
of pregnancy (15;16). The ERα-null mice are impaired in uterine growth and 
preparedness for blastocyst attachment (15). The PR-null mice display a refractory uterus 
that fails to respond to a deciduogenic stimulus (16). A number of studies employing 
gene expression profiling have explored steroid-regulated pathways that control epithelial 
and stromal functions during implantation in mice (19-22). Although these studies have 
identified several potential target genes for both ER and PR, the precise mechanisms by 
which these factors mediate hormone-regulated functions in the uterus remain unclear. 
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Identification of C/EBPβ  as a novel target of steroid regulation in pregnant uterus 
Gene expression profiling in pregnant uterus identified steroid-regulated gene 
networks that have functional relevance in implantation (23;24). Our studies identified 
CCAAT/Enhancer Binding Protein beta (C/EBPβ) as a novel mediator of the biological 
actions of E and P in mouse uterus (23;24). This transcription factor belongs to a family 
of basic leucine zipper (bZIP) proteins, which regulate numerous biological processes, 
including cell proliferation, differentiation, metabolic homeostasis, acute phase 
inflammation and apoptosis (25-27). The C/EBP family members regulate transcription 
of target genes by binding to a consensus nucleotide sequence motif, ATTCGG/CCAAT, 
which resides in the regulatory regions of these genes. Previous studies indicated that 
C/EBPβ is a critical regulator of proliferation and/or differentiation in multiple tissues 
including the liver, adipose tissue, immune system, skin cells and mammary gland (28-
36). In the liver and mammary gland, it displays growth-promoting function (31-33). In 
contrast, it exerts an antiproliferative action in epidermal keratinocytes and contributes to 
their growth arrest (36). C/EBPβ is, therefore, implicated in both positive and negative 
control of cell proliferation, depending on the cellular context. 
 
Figure 1.2 Expression of C/EBPβ during normal gestation.  
Uterine sections were prepared from tissues collected at days 4-7 of pregnancy and 
analyzed by IHC using anti-C/EBPb antibody. Panels D4 to D7 represent pregnant uteri 
at days 4, 5, 6, and 7 of gestation.  (Adapted from S. R.. Mantena et al. Proc. Natl. Acad. 
Sci. USA, 2006. ) 
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Administration of either E or P to ovariectomized non-pregnant mice induced 
C/EBPβ mRNA and protein in the uterine epithelial as well as stromal cells (23). Since 
these cells express ER and PR, and the induction by each hormone is lost in the absence 
of its cognate receptor, it is clear that the expression of this gene is controlled directly or 
indirectly by these receptors. During normal pregnancy in mice, a markedly enhanced 
expression of C/EBPβ occurred predominantly in the stromal compartment during the 
decidualization phase (Fig. 1.2).  
Following blastocyst attachment to the epithelium, the underlying stromal cells 
undergo extensive proliferation and differentiation that result in their transformation into 
the decidual cells (37-40). In rodents, decidualization can also be experimentally induced 
by scratching or introduction of a drop of oil in steroid hormone-primed uteri (14;41). We 
found that the expression of C/EBPβ is robustly induced in the decidual tissue during 
normal as well as experimentally induced decidual reaction. The decidual stage-specific 
expression of C/EBPβ likely arises from a complex interplay of E and P within the 
uterine compartments. Although a transient rise in E in the preimplantation period 
induces C/EBPβ in the stromal compartment of pregnant uterus, it appears that as these 
cells become progressively differentiated, PR becomes a critical regulator of this gene. 
This view is strongly supported by the observation that RU486, an antagonist of PR, 
efficiently suppressed stromal C/EBPβ expression when administered on day 6 of 
pregnancy (23). 
Role of C/EBPβ in female reproduction: insights from the knockout mouse 
Development of a C/EBPβ-null mouse model indicated that female mice lacking 
C/EBPβ are infertile, while the mutant males are fertile (29). The infertility of C/EBPβ-
null females was initially attributed to an impaired corpus luteal function. Consistent with 
this finding, transplantation of wild-type ovaries into C/EBPβ-null mice restored the 
formation and function of corpora lutea. This intervention, however, resulted only in a 
poor rescue of the pregnancy outcome. When normal ovaries were transplanted into 
C/EBPβ-deficient mice, only rare pregnancies were observed. In contrast, exchange of 
one ovary of wild-type females with a mutant ovary did not affect pregnancy outcome 
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and produced about 12-14 pups per litter. These results hinted at additional reproductive 
abnormalities in the mutant female, presumably at the level of the uterus. Starting from a 
mixed 129Sv X C57BL/6 genetic background of the C/EBPβ−null mice, we have now 
established a line with >90% 129Sv background through repeated breeding into this 
background. In collaboration with the Johnson group, we have identified multiple 
functional abnormalities in the uterine tissue of the mutant mouse (23;24). Embryos 
transferred to pseudopregnant uteri of C/EBPβ-null mice failed to implant. The uterine 
defects in the mutant mice included a reduced epithelial cell proliferation in response to E 
and a lack of stromal response to a deciduogenic stimulus. These phenotypic defects were 
observed in the presence of exogenously administered steroid hormones, indicating that 
they were independent of ovarian malfunction and intrinsic to the uterus. 
 
Figure 1.3 C/EBPβ  is essential for decidual response.  
WT (left panel) and C/EBPβ knockout  (KO) (right panel) mice were subjected to 
artificial decidual stimulation for 72 h. For each mouse, one uterine horn was stimulated, 
while the other horn was left undisturbed. Histological analysis by hematoxylin and eosin 
staining of representative uterine sections obtained from a stimulated WT (left panel) and 
C/EBPβ KO (right panel) mice subjected to artificial decidualization protocol. (Adapted 
from S. R. Mantena et al. Proc. Natl. Acad. Sci. USA, 2006.) 
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C/EBPβ  regulates stromal cell proliferation during decidualization 
During decidualization, the uterine stromal cells undergo proliferation followed 
by differentiation (37-40) (41). To investigate the decidualization defect in C/EBPβ-null 
mice, Mantena et al monitored the proliferation of steroid hormone-primed stromal cells 
in response to a mechanical decidual stimulus, using known markers of this event. Uteri 
of WT mice exhibited an intense staining for Ki67, predominantly in the stromal cells, 
within 24 h of receiving the decidual stimulus, clearly indicative of extensive stromal cell 
proliferation, which is also seen during normal pregnancy in response to embryo 
attachment. In contrast, the uterine sections from C/EBPβ-null mice showed greatly 
reduced Ki67 staining under identical conditions, implying a defect in stromal cell 
proliferation in the mutant mouse (23). A major goal of my research is to investigate the 
molecular basis of the mitotic arrest of the C/EBPβ-null uterine stromal cells. This work 
is described in Chapter 2.  
C/EBPβ  is a critical regulator of decidualization in the mouse 
The expression of C/EBPβ in the stroma during decidualization prompted our 
laboratory to analyze the functional role of this transcription factor during this process. 
The C/EBPβ-null females are infertile (29). To initially examine whether these mutant 
mice can support pregnancy at all, Mantena et al performed embryo-transfer experiments. 
Blastocysts were collected from uteri of wild-type (WT) females on day 4 of pregnancy. 
These blastocysts were then transferred directly into the uteri of pseudopregnant WT or 
C/EBPβ-null females on day 4 of pseudopregnancy. Five days after the embryo transfer, 
the numbers of implanted embryos as well as the size of the decidua in the recipient uteri 
were examined. Mantena et al found that the majority (>90%) of the transferred embryos 
did not implant in C/EBPβ-null recipients and a few that were present in the uterus did 
not grow or form any significant decidua (23). These results indicated that uterine 
functions are severely compromised in the C/EBPβ-null mice.  
Considering the possibility that the impairment in implantation and 
decidualization in the C/EBPβ-null mice could arise from a potential inadequacy of 
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ovarian hormone synthesis or release, Mantena et al administered steroid hormones to 
these mice and assessed the response of the hormone-primed uteri to a decidual 
stimulation in an experimentally induced decidualization experiment. In this protocol, 
uteri of ovariectomized WT and C/EBPβ-null mice were treated with a well-established 
regimen of E and P and then decidualization reaction was initiated in the left uterine horn 
by mechanical stimulation with a blunt needle while the right horn was left unstimulated 
(13, 41). Mantena et al then examined the morphology of the stimulated and unstimulated 
uterine horns of WT and C/EBPβ-deficient mice (23). As expected, the uterine horn of 
WT mice exhibited a robust decidual response within 72 h after receiving the mechanical 
stimulation. In contrast, the C/EBPβ-null uteri under identical conditions failed to show 
any significant decidualization. Histological examination of WT and null uteri further 
revealed that the stimulated WT horn was packed with decidual cells (Figure 1.3, left). In 
contrast, similarly treated uterine horns of C/EBPβ-null animals exhibited a markedly 
reduced mass of decidual cells (Fig. 1.3, right). Our studies clearly indicated a severe 
impairment of the decidualization process in the C/EBPβ-null mice and suggested a 
critical role of this transcription factor in supporting the stromal cell differentiation 
program in steroid hormone-primed uterus. 
The decidualization defect in C/EBPβ-null mice was also confirmed by 
examining the biochemical markers of this process. Mantena et al reported that the 
expression of alkaline phosphatase, a classical marker of decidualization of stromal cells 
(42), was prominent in the antimesometrial decidual cells of the WT uteri at 72 h after 
decidual stimulation. In contrast, no expression of this decidual marker was seen in the 
uteri of C/EBPβ-null mice at a similar time point, indicating a complete blockade of 
stromal decidualization. It is important to mention that the stromal expression patterns of 
PR and ERα in the C/EBPβ-null mice are comparable to those of the WT mice. The loss 
of stromal cell proliferation and differentiation in the null mice, therefore, does not arise 
from an aberrant steroid signaling due to a lack of PR and ERa in this compartment, but 
is rather a direct functional consequence of C/EBPβ-deficiency. 
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Potential role of C/EBPβ  in proliferation and decidualization of human 
endometrium 
During each menstrual cycle, the human endometrium first passes through an E-
dominated proliferative phase (d 1-14) involving extensive epithelial regeneration and 
then enters a P-dominated secretory phase (d 15-28) during which maturation and 
predecidualization of the stromal compartment occurs in preparation for embryo 
implantation (43;44). Predecidualization is a process that begins the transformation of 
stromal cells into decidual cells. It is initiated in stromal cells surrounding the spiral 
arteries during the mid-late secretory stage of the cycle. If pregnancy ensues, a full-blown 
decidualization spreads throughout the stroma under the continued influence of E and P. 
The putative implantation window in the human opens for a short period of time in the 
mid secretory stage of the cycle (d 20-24)(45). Decidualization of endometrial stroma is 
essential for successful implantation in the human.  
The molecular cues that are known to influence proliferation and decidualization 
of the human endometrium include steroid hormones E and P, growth factors and 
cytokines such as leukemia inhibitory factor (LIF), heparin-binding epidermal growth 
factor (HB-EGF), and interleukin-11, and the regulators of extracellular matrix such as 
matrix metalloproteases (44;46-50). The identities of the steroid-regulated pathways that 
control the proliferation and decidualization process are largely unknown. Induction of a 
few steroid-regulated molecules such as prolactin (PRL), IGFBP-1 and Hoxa10 during 
decidualization have been described, but their precise functions during decidualization 
remain unclear (51-54). Our recent studies revealed an intense nuclear expression of 
C/EBPβ in both epithelial and stromal compartments during proliferative and secretory 
phases of the menstrual cycle (55). An intense nuclear expression of C/EBPβ in glandular 
epithelium and differentiating stroma of human endometrium during the mid secretory 
phase of the cycle (55). These findings raised the possibility that C/EBPβ-regulated 
pathways control HESC function during various stages of the menstrual cycle. 
Extensive earlier studies have shown that endometrial stromal cells isolated from 
biopsies collected at the proliferative stage of the menstrual cycle can either proliferate or 
undergo differentiation, depending on the culture conditions (51;56;57). Several 
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laboratories have shown that the HESCs can be maintained in proliferating state for many 
generations or induced to undergo differentiation in response to a hormonal cocktail 
containing P, E, and a cAMP analog (51;56-59). This primary culture system, therefore, 
presents a unique opportunity to explore the role of C/EBPβ in HESCs proliferation and 
differentiation. We observed that C/EBPβ expression is markedly induced concomitant 
with stimulation of HESC proliferation by high serum and the addition of the hormonal 
cocktail. These finding raised the possibility that this transcription factor is a critical 
driver of endometrial stromal proliferation and differentiation in the human. A major goal 
of my research is to exploit this in vitro culture system to identify C/EBPβ-regulated 
downstream pathways during stromal proliferation and differentiation in human. This 
work is described in Chapter 3 and Chapter 4.  
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CHAPTER 2 
The CCAAT/Enhancer Binding Protein Beta (C/EBPβ) is a Critical Regulator of 
Steroid-Induced Mitotic Expansion of Uterine Stromal Cells during Decidualization 
2.1 Abstract 
During early pregnancy, the concerted actions of the maternal steroid hormones, 
estrogen and progesterone, promote a unique process known as decidualization, which 
involves extensive proliferation and differentiation of uterine stromal cells. The 
molecular pathways underlying this hormonally induced cellular transformation, an 
essential prerequisite for embryo implantation, remain poorly understood. We previously 
identified the transcription factor C/EBPβ as a target of steroid regulation in the uterus. 
Uteri of mice lacking C/EBPβ failed to undergo decidualization. In the present study, 
analyses of C/EBPβ-null uteri indicated that loss of this factor leads to a block in stromal 
cell proliferation in response to a decidual stimulation. The mutant stromal cells entered S 
phase of the cell cycle and completed DNA synthesis but were unable to execute mitosis. 
Further analysis revealed that C/EBPβ facilitates the transition of these cells into mitosis 
by binding directly to the cyclin B2 promoter to regulate the expression of this cyclin. 
The expression of cdc25C, a phosphatase that maintains the active state of the cyclin B-
cyclin-dependent kinase complex during mitosis, is strongly suppressed in C/EBPβ-null 
stromal cells, uncovering additional mechanisms by which C/EBPβ controls G2-M 
transition. Furthermore, the expression of the tumor suppressor p53 and the cell cycle 
inhibitors p21 and p27 was markedly elevated in C/EBPβ-null stromal cells prior to the 
mitotic phase. Collectively, these results revealed that C/EBPβ mediates the effects of 
steroid hormones during decidualization by modulating the expression of multiple key 
cell cycle regulatory factors that control the G2-M transition of the proliferating uterine 
stromal cells. 
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2.2 Introduction 
The mouse model has been used extensively to study the molecular signaling 
mechanisms underlying the process of embryo implantation (1;2). During the 
preimplantation phase of pregnancy in this species, the maternal steroid hormones, 
estrogen (E) and progesterone (P), orchestrate molecular and cellular alterations in the 
uterine surface epithelium that make it competent to attach to the blastocyst to initiate the 
process of implantation (3-6). The attachment of the blastocyst on day 4.5 of pregnancy 
triggers the process of decidualization, which involves a remarkable transformation of the 
fibroblastic endometrial stromal cells underlying the surface epithelium into 
morphologically and functionally distinct decidual cells (7-12). This cellular 
transformation process occurs under the influence of E and P during days 5-8 of 
gestation. Initially the undifferentiated stromal cells undergo mitotic expansion, and then 
they enter the differentiation program that converts them into decidual cells. The 
formation of the decidual tissue surrounding the implanting embryo is a prerequisite for 
successful implantation. It is well documented that the uterine stromal cells acquire 
unique secretory and biosynthetic activities upon differentiation. They serve as a source 
of paracrine effectors such as hormones, growth factors and cytokines, which promote 
uterine angiogenesis and embryo development, mediate immunoregulatory functions 
during pregnancy, and regulate trophoblast invasion (7-12). An important challenge in the 
study of implantation biology is to understand the complex process by which steroid 
hormones regulate the formation and function of the decidual tissue. To this end, it is 
critical to identify and characterize the factors induced by the maternal hormones that 
regulate the proliferation and differentiation of uterine stromal cells during the 
decidualization process. 
We previously employed gene expression profiling in pregnant mouse uterus to 
identify steroid-regulated gene networks that have functional relevance in implantation 
(13;14). Our studies identified CCAAT/Enhancer Binding Protein beta (C/EBPβ) as a 
novel mediator of the biological actions of E and P in the uterus during early pregnancy 
(13;14). This transcription factor belongs to a family of basic leucine zipper (bZIP) 
proteins, which controls numerous biological processes, including cell proliferation, 
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differentiation, metabolic homeostasis, acute phase inflammation and apoptosis (15-17). 
The C/EBP family members regulate transcription of target genes by binding to a 
consensus nucleotide sequence motif, ATTCGG/CCAAT, which resides in the regulatory 
regions of these genes. Previous studies revealed that female mice lacking C/EBPβ are 
infertile, while the mutant males are fertile (18). The infertility of C/EBPβ-null females 
was initially attributed to impaired corpus luteal function. In subsequent studies, we 
demonstrated that multiple functional abnormalities in the uterine tissue of the mutant 
mouse also contribute to the observed infertility (13;14). The uterine defects in the 
mutant mice included a reduced epithelial cell proliferation in response to E and a lack of 
stromal response to a deciduogenic stimulus (13). These phenotypic defects were 
observed in the presence of exogenously administered steroid hormones, indicating that 
they were independent of ovarian malfunction and intrinsic to the uterus. 
During the decidualization phase of pregnancy, the uterine stromal cells undergo 
proliferation for 24-48 h and then enter the differentiation program (19-22). The lack of 
decidual response in C/EBPβ-null uteri indicated that this transcription factor is a 
potential regulator of pathways directing stromal proliferation or differentiation or both. 
Morphological analysis of uterine sections of wild-type (WT) and C/EBPβ-null uteri in 
response to decidual stimulus showed a significantly reduced stromal/decidual cell mass 
in the mutant mice, hinting at a defect in uterine stromal cell proliferation in these mice. 
In the present study, we tested the hypothesis that C/EBPβ regulates stromal cell 
proliferation during decidualization by controlling the expression or activity of critical 
cell cycle regulatory molecules. We performed a detailed analysis of the expression and 
function of potential cell cycle regulators in the stromal compartment of C/EBPβ-null 
uteri to pinpoint the molecular defect(s) underlying the lack of decidual response in the 
mutant tissue.  
Our study revealed that, in response to decidual stimulation, C/EBPβ-null uterine 
stromal cells are able to progress through the G1 and S phases of the cell cycle, but failed 
to undergo mitosis. The mutant cells displayed markedly reduced levels of cyclin B2 and 
cdc25C phosphatase, two key regulators of mitosis. We further confirmed that C/EBPβ 
directly binds to cyclin B2 promoter to regulate its expression. Additionally, we observed 
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an increased expression of the cell cycle suppressors, p53, p21 and p27, in the mutant 
cells prior to mitosis. Collectively, these results indicated that C/EBPβ plays a vital role 
in decidualization by controlling the expression or activity of multiple cell cycle 
regulatory molecules that critically control G2-M transition. 
2.3 Materials and Methods  
Animals and Tissue Collection 
All experiments involving animals were conducted in accordance with the 
National Institutes of Health standards for the use and care of animals. The animal 
protocols were approved by the University of Illinois Institutional Animal Care and Use 
Committee. Female 129-SV mice (from Charles River, Wilmington, MA) and C/EBPβ-
null mice of same genetic background were subjected to experimentally induced 
decidualization. Mice were euthanized at various time points following the administration 
of the artificial decidualization stimulus and uteri were collected. 
Experimentally induced decidualization 
Decidualization was induced artificially as described previously (23). Briefly, 
mice were subjected to bilateral ovariectomy. Two weeks following ovariectomy, animals 
were injected with 100 ng of estrogen (Sigma) in 0.10 ml of sesame oil for three 
consecutive days. This was followed by 2 days of rest, and then administration of daily 
injections of 1 mg of progesterone (Sigma) and 10ng estrogen for three consecutive days. 
Six hours after the third P and E injection, 20µl sesame oil was injected into uterine horn 
to mimic the decidualization stimulus.  
Isolation of primary stromal cells and analysis of decidualization in vitro: 
Mouse uteri were collected at various time points following artificial 
decidualization and uterine stromal cell were isolated as described previously (24). 
Briefly, uterine horns were dissected and cut into 3-5 mm pieces. After washing with 
Hank's balanced salt solution (HBSS, Invitrogen), uterine tissues were placed in HBSS 
containing 6 g/liter dispase (Invitrogen) and 25g/liter pancreatin (Sigma) for 1 h at room 
 20 
temperature and then 10 min at 37 °C. The tissues were gently mixed and the supernatant 
was discarded to remove the endometrial epithelial clumps. The partially digested tissues 
were washed twice in HBSS and then placed in HBSS containing 0.5g/liter collagenase 
(Sigma). After incubation for 45 min at 37 °C, the tubes were vortexed for 10-12 s until 
the supernatant became turbid with dispersed endometrial stromal cells. The contents of 
the tube were then passed through a 70-µm gauze filter (Millipore). The stromal cells in 
the filtrate were pelleted, re-suspended in Dulbecco's modified Eagle's Medium-F12 
medium (DMEM-F12 supplemented with 100 unit/liter penicillin, 0.1 g/liter 
streptomycin, 1.25 mg/liter fungizone, Invitrogen) containing 5% fetal calf serum 
(Atlanta Biological), and plated. The unattached cells were removed by washing with 
HBSS, and cell culture was continued after addition of fresh medium supplemented with 
P (1 µM) and E (10 nM) as described previously (24). 
Immunohistochemistry and Immunocytochemistry 
Paraffin-embedded endometrial sections were subjected to immunohistochemistry 
as described previously (25). Polyclonal antibodies against BrdU and phospho-histone 3 
(Santa Cruz Biotechnology) were used for immunohistochemistry at dilutions of 1:500 
and 1:1000, respectively. Mouse primary stromal cell were fixed and subjected to 
immunocytochemistry using antibodies against cyclin B2, Cdk1, cdc25C and phospho-
Cdk1 (Thr14/Tyr15) (Santa Cruz Biotechnology).  
Western Blotting:  
Stromal cell were isolated from uteri collected from mice at different times after 
artificial decidual stimulus as described previously (26). The cells were lysed in ice-cold 
lysis buffer containing 25 mM Tris/HCl, pH 7.4, 50 mM NaF, 100 mM NaCl, 1 mM 
sodium vanadate, 5 mM EGTA, 1 mM EDTA, 1% (v/v) Triton X-100, 10 mM sodium 
pyrophosphate, 1 mM benzamidine, 0.1 mM PMSF, 0.27 M sucrose, 2 µM microcystin 
and 0.1% (v/v) 2-mercaptoethanol. The cell debris was removed by centrifugation and the 
protein concentration of the lysate was determined by the method of Bradford, using BSA 
as a standard. The cell lysates were analyzed by western blotting using antibodies against 
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cyclin B2, cyclin A, Cdk1 (Santa Cruz Biotechnology), and p53, p21, p27 (Cell Signaling 
Technology).  
Chromatin immunoprecipitation (ChIP) analysis. 
The ChIP analysis was performed using the EZ ChIP (Upstate Biotechnology), 
according to the manufacturer’s protocol. Briefly, mouse uterine stromal cell were 
isolated from wild type mice subjected to artificial decidualization protocol and cultured 
in the presence of E and P for 21 h. The cells (8X106) were then placed in PBS buffer and 
cross-linked with 1% formaldehyde for 10 min. The cross-linked cells were harvested, 
lysed using SDS lysis buffer, and sonicated. After pre-clearing the lysates with salmon 
sperm DNA–protein A at 4 °C for 2 h, the DNA–protein complexes in the supernatant 
were immunoprecipitated using antibodies against RNA polymerase II, mouse IgG 
(Upstate Biotechnology) or C/EBPβ (Santa Cruz Biotechnology). The immune 
complexes were recovered by adding protein A agarose. The beads then were washed 
repeatedly and the bound complexes were eluted using the elution buffer. The cross-
linking was reversed and then proteins were digested using 0.5 mg/ml proteinase K. 
Purified DNA were used as templates for PCR using various primer sets to amplify 
specific regions of the cyclin B2 promoter.  
Adenovirus-mediated expression of dominant negative C/EBPβ   
An adenoviral vector expressing a dominant negative mutant of C/EBPβ (A-
C/EBP) was provided by Dr. Charles Vinson (NCI/NIH). This vector expresses A-C/EBP 
under the control of CMV promoter. The protein is expressed with a HA epitope tag. An 
adenoviral vector lacking the A-C/EBP insert and expressing GFP was used as a control. 
Stromal cells were isolated from WT uteri collected immediately after artificial decidual 
stimulation, and allowed to attach to slides for 2 h. Then the cells were cultured in 
medium supplemented with P (1 µM) and E (10 nM) and transduced with adenovirus 
expressing dominant-negative A-C/EBP or control virus (Ad-GFP) (MOI is 10:1) or no 
virus treated. After 20 h transduction, Stromal cells were treated with formaldehyde and 
ChIP assays were performed as described above.  
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Statistical Analysis 
All experiments were repeated at least three times. For preparation of RNA and 
protein samples, the uteri were pooled from at least three mice subjected to the same 
experimental treatment. The real-time PCR results are expressed as mean ± S.D of three 
separate measurements. Statistical significance of the data was determined using one-way 
ANOVA followed by student t-test. A p-value of <0.05 was considered significant. 
2.4 Results  
C/EBPβ-null uterine stromal cells undergo DNA replication in response to a decidual 
stimulation 
To investigate the role of C/EBPβ in the proliferation of steroid hormone-primed 
uterine stromal cells, we subjected WT and C/EBPβ-null mice to experimentally induced 
decidualization. Non-pregnant, cycling WT or C/EBPβ-null mice were ovariectomized, 
rested for two weeks, and treated with a regimen of E and P as per standard protocol (13). 
Uterine horns of these animals were then subjected to a decidual stimulation as described 
in the Materials and Methods. To assess DNA synthesis, we monitored the incorporation 
of bromodeoxyuridine (BrdU) in uterine tissue at different times following decidual 
stimulation. Previous studies in our laboratory indicated a marked increase in BrdU 
incorporation in WT uterine stroma at 12 h following decidual stimulation (Wei Wang, 
and M. K. Bagchi, unpublished observation). Therefore, to examine the S phase activity 
in the stromal tissue, we administered a two-hour pulse of BrdU at 12 and 14 h following 
the decidual stimulation and collected uteri at 14 and 16 h, respectively. In the WT 
animals, a significant portion of the uterine stroma, particularly the sub-luminal stromal 
cells, exhibited BrdU immunostaining by 14 h (Fig. 2.1 A, left, top panel). By 16 h, 
strong and widespread BrdU incorporation was seen in the stromal compartment of WT 
uteri (Fig. 2.1 A, right, top panel). Sections of C/EBPβ-null uteri collected at the same 
time points following decidual stimulation exhibited similar robust incorporation of BrdU 
(Fig. 2.1 A, bottom panels). Consistent with these results, quantitation of the BrdU 
immunostaining revealed no significant difference in the number of BrdU-positive cells 
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in the stromal compartments of the WT and C/EBPβ-null uteri (Fig. 2.1B).  The stromal 
cells of C/EBPβ-null uteri, therefore, were able to progress through the G1-S checkpoint, 
enter the S phase and execute DNA synthesis. 
C/EBPβ-null uterine stromal cells exhibit impaired mitosis 
To monitor the mitotic activity of these mutant stromal cells, we employed an 
antibody, which recognizes phosphorylated Ser 10 of histone 3 (P-His3), a unique mitotic 
phase marker (27). In animal cells, the Ser 10 phosphorylation of H3 begins in 
pericentromeric heterochromatin in late G2 interphase cells. As mitosis progresses, the P-
His3 mark spreads throughout the condensing chromatin, and this modification is 
complete in most cells by the time prophase chromosomes are formed (27). We observed 
that by 20 h following decidual stimulation, a large number of the stromal cells in the WT 
uteri displayed specific staining for P-His3, suggesting that they undergo mitotic division 
(Fig. 2A, upper panel). In contrast, markedly reduced and only sporadic staining for P-
His3 was seen in the stromal compartment of C/EBPβ-null uteri at a similar time point, 
indicating that the majority of the mutant cells are unable to proceed through mitosis 
(Fig. 2.2 A, lower panel). Quantitation of the immunofluorescence signal indicated an 
approximately 5-fold decrease in P-His3 staining in C/EBPβ-null stromal cells relative to 
the WT cells (Fig. 2.2 B). Examination of sections of uterine tissue obtained from the null 
animals at later time points, such as 22 and 24 h, also did not indicate any substantial 
immunostaining for P-His3 (data not shown), confirming that mitosis is not delayed but 
truly impaired in the mutant stromal cells. The reduced mitotic activity of the C/EBPβ-
null uterine stromal cells indicated that these cells, which are able to undergo DNA 
replication, are arrested in the cell cycle prior to mitosis, presumably at the G2-M 
boundary. 
C/EBPβ  controls the expression of cyclin B at G2-M transition of the cell cycle 
The cell cycle is primarily regulated by a complex interplay of cyclins, cyclin-
dependent kinases (Cdks) and cyclin-dependent kinase inhibitors (28-31). We, therefore, 
investigated whether C/EBPβ controls the proliferation of stromal cells by regulating the 
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expression of certain of the molecules that specifically control various cell cycle 
checkpoints. Uteri were collected from WT and C/EBPβ-null mice at different times after 
experimentally induced decidualization and the stromal cells were isolated from these 
tissue samples. We then monitored the expression of specific cyclins and Cdks that are 
hallmarks of G1-S and G2-M phases.  
Previous studies showed that cyclin D3 and cyclin E1 are predominant D-type and 
E-type cyclins, respectively, in mouse stromal cells (32). As shown in Fig. 3, panels A-D, 
the expression levels of mRNAs corresponding to cyclin D3, cyclin E1, Cdk4 and Cdk2, 
which are critical regulators of G1-S transition, were elevated in uterine stromal cells of 
both WT and C/EBPβ-null mice at 15 h following decidual stimulation. We also noted 
that their expression declined at 18 h in WT as well as C/EBPβ-null mice as the cells 
completed the S phase and entered the G2 phase. There was no statistically significant 
difference between the expression levels of these cyclins and cdks in uterine stromal cells 
of WT and C/EBPβ-null mice. Additionally, no significant alteration in the expression 
level of the mRNA encoding cdc25A, a phosphatase that regulates Cdk4 activity, was 
observed between WT and C/EBPβ-null uterine stromal cell (Fig. 2.3, panel E). 
Collectively, these results are consistent with our observation in Fig. 2.1 that the lack of 
C/EBPβ does not affect the advancement of the stromal cells through the S phase of the 
cell cycle. 
We next examined the expression of several factors such as Cyclin B, Cyclin A, 
and Cdk1, which are critical for the entry of the stromal cells into the mitotic phase. 
During the G2-M transition, binding of cyclin A or cyclin B to Cdk1 induces 
phosphorylation and activation of this kinase, which plays a critical role in this process. 
As shown in Fig. 2.4, panels A and B, no significant alteration in stromal expression of 
cyclin A or Cdk1 mRNA was seen in the C/EBPβ-null uteri relative to the WT uteri at 
either 16 or 20 h following decidual stimulation. In contrast, the expression of cyclin B1 
and cyclin B2 mRNAs was significantly reduced in C/EBPβ-null uterine stromal cells, 
particularly at 20 h following decidual stimulation, when the cells are supposed to enter 
the mitotic phase (Fig. 2.4, panels C and D). It is pertinent to mention here that cyclin B2 
mRNA is expressed at a higher level compared to cyclin B1 mRNA in the uterine stromal 
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cells (Wei Wang, unpublished data). Whereas the mRNA level of cyclin B1 decreased by 
~50% in uterine stromal cells lacking C/EBPβ, that of cyclin B2 decreased by more than 
80%. 
To further validate the regulation of cyclin B2 by C/EBPβ, we analyzed its 
expression at the protein level. As shown in the western blot in Fig. 2.4E, the signal(s) of 
cyclin B2 was drastically reduced in cell lysates prepared from stromal cells obtained 
from C/EBPβ-null uteri subjected to experimentally induced decidualization. We also 
monitored cyclin B2 expression using immunocytochemistry in primary uterine stromal 
cells undergoing decidualization in vitro. Under these conditions, we observed a strong 
nuclear expression of cyclin B2 in WT stromal cells undergoing mitosis at 20 h following 
the initiation of the decidualization process (Fig. 2.4F). This immunostaining of cyclin 
B2 was markedly diminished in the stromal cells isolated from C/EBPβ-null uteri and 
cultured under similar conditions. Our results supported the concept that C/EBPβ is a 
critical regulator of the B-type cyclins, B1 and B2, which control the transition of the 
uterine stromal cells into mitosis. 
C/EBPβ manifests its transcriptional function by binding to the CCAAT motifs at 
the promoter regions of its target genes to directly influence their rate of transcription. In 
silico analysis of the promoter of cyclin B2, using the bioinformatics softwares TESS, 
TFSearch and Consite, revealed that it contains four candidate C/EBPβ binding sites 
within the 2 kilo-base 5‘-flanking region of the gene at approximately -403, -686, -930 
and –1651 relative to the transcription start site. To test whether C/EBPβ actually binds 
to one or more of these sites, we employed chromatin immunoprecipitation using an 
antibody specific for C/EBPβ. As shown in Fig. 2.5A, when primary cultures of uterine 
stoma cells were subjected to in vitro decidualization, no significant binding of 
C/EBPβ was detected at the –403, –686 and –1651 sites of the cyclin B2 promoter. In 
contrast, a relatively strong binding of this transcription factor was observed at the cyclin 
B2 promoter region -930.  
To further ascertain that the –930 region of the cyclin B2 promoter represents a 
functional C/EBPβ binding site, we employed a dominant-negative mutant of C/EBPβ. 
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Previous studies showed that this mutant, A-C/EBP, which lacks the DNA binding 
domain but retains the dimerization domain, inhibits DNA binding and transcriptional 
function of endogenous C/EBPβ (33). Primary stromal cells were transduced with 
recombinant adenovirus expressing A-C/EBP (Fig. 2.5B) or control adenovirus 
expressing GFP. As shown in Fig. 2.5C, A-C/EBP, which inhibits DNA binding and 
transcriptional activity of endogenous C/EBPβ, abolishes the occupancy of the –930 
region of the cyclin B2 promoter by this transcription factor. These data demonstrated 
that the -930 region of the cyclin B2 promoter represents a bonafide C/EBPβ binding site 
and it likely mediates the direct regulation of the expression of this cyclin by C/EBPβ. 
Loss of cdc25C expression in C/EBPβ-null uterine stromal cells may contribute to 
decreased Cdk1 activity leading to G2-M arrest 
cdc25C is a cell cycle regulatory phosphatase, which is a critical regulator of 
Cdk1 activity. It maintains Cdk1 activity during mitosis via the reversal of inhibitory 
phosphorylations at Thr14 and Tyr15 of Cdk1. We observed that the level of cdc25C 
mRNA was markedly down regulated in C/EBPβ-null uterine stromal cells relative to the 
WT stromal cells at the time of G2-M phase transition (Fig. 2.6A). This result was further 
confirmed upon analysis of the levels of cdc25C protein in uterine stromal cells subjected 
to in vitro decidualization. Immunocytochemical analysis revealed that the expression of 
cdc25C was significantly reduced in the C/EBPβ-null uterine stromal cells, while Cdk1 
was expressed at similar levels in WT and mutant stromal cells (Fig. 2.6, panels B and 
C), 
To ascertain that the down regulation of cdc25C expression in C/EBPβ-null 
uterine stromal cells indeed affects the inhibitory phosphorylation status of Cdk1 at 
Thr14/Tyr15, we performed immunocytochemistry using an antibody which specifically 
recognizes this modification. Our results confirmed that the level of p-Cdk1 was higher in 
C/EBPβ-null uterine stromal cells relative to the WT cells (Fig. 2.6, panel D). These 
results are consistent with the hypothesis that the regulation of the expression of cdc25C 
represents an additional mechanism by which C/EBPβ controls the activity of Cdk1 
during mitotic entry. 
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Elevated expression of cell cycle inhibitors in C/EBβ-null uterine stromal cells 
It is well documented that cyclin-dependant kinase inhibitors p21 and p27, and 
the cell cycle suppressor p53 inhibit the activity of various cyclin-Cdk complexes, 
resulting in the arrest of the cell cycle at the G1-S and G2-M checkpoints (34-39). To 
determine whether C/EBPβ controls uterine stromal proliferation by regulating the 
expression of these cell cycle suppressors, we analyzed the levels of their mRNAs in WT 
and C/EBPβ-null uterine stromal cells by real-time PCR (Fig. 2.7A). We found that the 
expression of p53 mRNA was modestly increased in C/EBPβ-null stromal cells at 16 h 
following decidual stimulation, while the levels of mRNAs corresponding to p21 and p27 
did not change significantly at this time point (Fig. 7, panels A-C). In contrast, the levels 
of p21, p27 and p53 mRNAs were markedly elevated in the mutant stromal cells at 20 h 
following the decidual stimulation when G2-M phase transition is supposed to occur. 
Similar changes in their protein levels were confirmed by Western blot analysis (Fig. 2.7, 
panel D). These results indicated that C/EBPβ-mediated stromal cell proliferation during 
decidualization is associated with the suppression of expression of p21, p27 and p53 
proteins during the G2-M phase transition. Loss of C/EBPβ expression in C/EBPβ-null 
stromal cells results in the up regulation of these inhibitors, which then repress the 
activity of cyclin B-Cdk1 complex and contribute to the blockade of stromal cell mitosis 
(Fig. 2.8). 
2.5 Discussion 
Previous studies indicated that C/EBPβ  is a critical regulator of cell proliferation 
and/or differentiation in multiple tissues including the liver, adipose tissue, immune 
system, skin and mammary gland (18;40-47). In the liver and breast, it promotes growth 
and proliferation of hepatocytes and mammary epithelium, respectively (45-47). In 
contrast, it exerts an antiproliferative action in epidermal keratinocytes and contributes to 
their growth arrest (42). C/EBPβ, therefore, is implicated in both positive and negative 
control of the cell cycle, depending on the cellular context.  
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This paper addresses the role of C/EBPβ in uterine stromal proliferation. During 
the decidualization phase of pregnancy, steroid hormone-primed uterine stromal cells 
undergo proliferation and mitotic expansion during the first 24-48 h following decidual 
stimulation (19-22;48). The precise mechanisms by which E and P regulate stromal 
proliferation and differentiation in the uterus remain unclear. We have previously 
reported that C/EBPβ is a mediator of the biological actions of E and P in mouse uterus 
(13). Its expression is robustly induced in the decidual tissue during normal as well as 
experimentally induced decidualization (13). The expression of C/EBPβ in decidual cells 
arises from a complex interplay of E and P within the uterine compartments. Although a 
transient rise in the level of E in the pre-implantation period induces C/EBPβ in the 
epithelial and stromal cells of pregnant uterus, PR becomes a critical regulator of this 
gene as the stromal cells become progressively differentiated (13). In this paper, we 
provide evidence that C/EBPβ plays a central role in controlling the stromal cell cycle 
during decidualization. This study, therefore, provides a molecular explanation of the 
gene regulatory pathways via which the steroid hormones execute the growth and 
expansion of uterine stromal population at the onset of decidualization. 
It is well established that the proliferation of animal cells proceeds through 
various stages of the cell cycle: G1, S, G2, and M, and is controlled at distinct 
checkpoints (28;31;49;50). Progression through each phase of the cell cycle is under the 
strict control of multiple regulatory factors, such as, cyclins, cyclin-dependent kinases 
(Cdks), and Cdk-inhibitors (28;31;49;50). Cyclin levels fluctuate dramatically through 
the cell cycle as a consequence of changes in transcription and ubiquitin-mediated 
degradation. Different cyclins bind specifically to different Cdks, which are 
serine/threonine protein kinases, to form distinct regulatory complexes at specific phases 
of the cell cycle and thereby drive the cell from one phase to another. The association of 
D-type cyclins with Cdk4 or Cdk6 is important for G1-S transition. Binding of B-type 
cyclins to Cdk1 allows phosphorylation of this enzyme by the Cdk-activating kinase 
(CAK) and its activation, which plays an essential role in G2-M transition. Our present 
study showed that the C/EBPβ-null stromal cells are able to enter the cell cycle and 
proceed through the S phase (DNA synthesis) in response to a decidual stimulation. 
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Consistent with this finding, we did not observe any significant change in the expression 
of cyclin D, cyclin E, Cdk2, Cdk4 and cdc25A, which control G1 to S phase transition 
and S phase activity, in WT versus mutant stromal cells.  
Strikingly, the C/EBPβ-null uterine stromal cells exhibited impaired mitosis. Our 
results suggested that the stromal cells are arrested at the G2-M checkpoint of the cell 
cycle in the absence of C/EBPβ. We considered the possibility that the expression of one 
or more critical regulators of G2-M transition is lost in the C/EBPβ-null uterine stromal 
cells. We found that the mRNAs corresponding to the B-type cyclins B1 and B2 are 
markedly down regulated in the mutant stromal cells compared to the WT cells. Our 
studies confirmed that the level of cyclin B2 protein declined sharply in the C/EBPβ-null 
stromal cells. Previous reports indicated that multiple CCAAT box-like motifs are located 
at human or mouse cyclin B2 promoter (51;52). To explore whether the C/EBPβ directly 
binds to the cyclin B2 promoter and regulates its expression, we employed the ChIP 
procedure. Our results demonstrated that C/EBPβ binds strongly to a specific region in 
the cyclin B2 promoter that contains a CCAAT-like motif. This finding is consistent with 
the hypothesis that C/EBPβ is a direct regulator of transcription of the cyclin B2 gene.  
Previous studies showed that targeted deletion of cyclin B1 gene resulted in 
embryonic lethality in mice (53). In contrast, mutant mice lacking cyclin B2 are viable 
and both sexes are fertile. However, mating of homozygous mice cyclin B2-null mice 
produced markedly reduced litter size, although the reason for this sub-fertility remain 
unclear (53). It was thought that cyclin B1, whose expression overlaps with that of cyclin 
B2 in many tissues, compensates for the loss of cyclin B2 in the mutant mice. We found 
that both cyclins B1 and B2 are expressed in the uterine stromal cells during pregnancy, 
although the cyclin B2 levels are significantly higher than that of cyclin B1. It is 
important to note that C/EBPβ controls the expression of both B-type cyclins. Therefore, 
the absence of this transcription factor would lead to a drastic reduction in the overall 
levels of B-type cyclins in the uterine stromal cells, consistent with the observed block in 
their mitotic activity.  
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A well-established mechanism to control entry into mitosis is to regulate the 
activity of the cyclin B/Cdk1 complex (31). The function of Cdk1 is tightly controlled by 
modulation of phosphorylation and dephosphorylation of this kinase (50). Binding of 
cyclin B triggers phosphorylation of Cdk1 by CAK, which leads to its activation. On the 
other hand, the Cdk1 activity is greatly reduced by inhibitory phosphorylation at Thr14 
and Tyr15 by the Wee1 and Myt1 kinases. Cdc25C, a cell cycle regulatory phosphatase, 
maintains the active state of Cdk1 through dephosphorylation of the Thr14 and Tyr15 
sites. We investigated whether C/EBPβ regulates the Cdk1 activity during mitosis by 
altering the expression of any of the kinases and phosphatases that control Cdk1 activity. 
While no change was seen in the expression of the kinases that modulate Cdk1 function 
(data not shown), we found that the expression of cdc25C is greatly reduced in the 
C/EBPβ-null uterine stromal cells. As expected, concomitant with the decrease in the 
level of cdc25C, there was a significant up regulation in the level of phospho-Cdk1 (Thr 
14/Tyr 15), which likely contributes to the mitosis block. 
Interestingly, we noted that the levels of several well-known cell cycle 
suppressors, p21, p27 and p53, were markedly elevated specifically at the time of G2-M 
transition. This finding uncovered additional mechanisms by which C/EBPβ controls 
stromal proliferation during decidualization progression. p53, an important cell cycle 
repressor, is a transcription factor induced and activated in response to various stress 
signals or DNA damage events (54). Numerous studies have shown that p53 is able to 
trigger cell cycle arrest at G1-S and G2-M checkpoints via different mechanisms 
involving its downstream transcriptional targets such as p21. Our results are in agreement 
with earlier findings of Yoon et al who demonstrated a striking increase of p53 
expression and function in the keratinocytes of C/EBPβ-null mice, indicating that 
C/EBPβ has a role in the negative regulation of p53 in normal keratinocytes (55). 
Previous reports also indicated that C/EBPβ is able to bind efficiently to the p53 
promoter and suppress its transcription (56). Conversely, p53 can repress the 
transcriptional activity of C/EBPβ by physically interacting with its C-terminal domain 
(57). This two-way cross-talk between C/EBPβ and p53 is likely to influence the 
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expression of both p53 and C/EBPβ and their downstream genes during the stromal 
decidualization process. 
p21, the transcriptional target of p53, binds directly to a broad spectrum of cyclin-
Cdk complexes and inhibits their function (37). Another well-known inhibitor, p27, also 
functions by binding to the G1/S and G2/M cyclins and interfering with their activities 
(38;39). Interestingly, the levels of p27 and p53-induced p21 did not change significantly 
in C/EBPβ-null uterine stromal cells at the time of G1-S transition following a decidual 
stimulation. We observed that the levels of p27 and p21 are elevated in the mutant 
stromal cells specifically at the time of G2/M transition, indicating that these cell cycle 
inhibitory molecules contribute to the G2/M block of stromal proliferation seen in the 
C/EBPβ-null mice.  
A comparison of the mechanisms by which C/EBPβ controls uterine stromal 
proliferation with previously reported mechanisms of its action in other tissues, such as 
the liver, adipose tissue and mammary gland, revealed interesting differences. In 
C/EBPβ-null female mice, mammary epithelial cells fail to proliferate in response to 
steroid hormones, leading to an impaired ductal morphogenesis (46;47). It was shown 
that loss of C/EBPβ in this tissue markedly reduced the expression of cyclin E, which 
contributed to a G1/S arrest (58). Additionally, the mutant mammary epithelial cells 
showed decreased cdc25A expression and increased p27 stability. Loss of C/EBPβ 
expression in models of liver regeneration showed a similar defect in cell cycle 
progression through the S phase, and it was mainly attributed to a lack of expression of 
cyclin E (45). In the C/EBPβ-null stromal cells, however, we did not find any defect in 
the G1-S transition as the cells were able to proceed through the S phase before their 
arrest at the G2-M checkpoint. These findings suggested that C/EBPβ regulation of cell 
proliferation is cell context specific and a unique regulatory strategy involving the control 
of the mitosis step operates during uterine stromal proliferation during decidualization. 
In summary, this study provides new insights into the mechanisms by which 
C/EBPβ mediates the effects of steroid hormones during decidualization. Our results 
show that C/EBPβ is a key regulator of the stromal proliferation and it operates by 
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controlling the expression and function of multiple cell cycle regulatory molecules that 
control the G2-M transition of the decidualizing stromal cells. This study is important 
because it provides a mechanistic understanding of the hormone-regulated pathways that 
control decidualization, which is a prerequisite for the successful establishment of 
pregnancy. 
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2.7 Figures and legends 
 
Figure 2.1 Examination of S phase activity of uterine stromal cells of C/EBPβ-null 
mice using BrdU immunostaining 
Ovariectomized WT and C/EBPβ-null mice were subjected to artificial decidual 
stimulation and uteri were collected at different time points following application of the 
stimulus. A: Mice were given BrdU injection at 12 and 14 h after stimulation. After a 2 h 
pulse, the uterine tissues were collected at 14 and 16 h. The tissues were fixed, embedded 
in paraffin, sectioned and subjected to IHC using an antibody specific for BrdU. At least 
three WT or C/EBPβ-null mice were used at each time point and representative data are 
shown. 
B. The number of cells in sections of C/EBPβ-null uteri that are immunoreactive to 
BrdU-antibody was quantitated and compared with those in WT uteri.  Data were 
expressed as average +/- S.D of three separate measurements. 
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Figure 2.2 Stromal proliferation is blocked at G2-M transition in C/EBPβ-null uteri 
Ovariectomized WT and C/EBPβ-null mice were subjected to artificial decidual 
stimulation and uteri were collected at different time points after application of the 
stimulus. A. Sections of uterine tissues obtained at 20 h after artificial decidual 
stimulation were subjected to immunofluorescence using an antibody specific for 
phosphorylated Ser 10 of histone 3. E and S denote surface epithelium and stroma, 
respectively. B. The number of phospho-histone 3-positive cells in C/EBPβ-null uteri 
was quantitated and compared with those in WT uteri.  Data were expressed as average 
+/- S.D of three separate measurements. 
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Figure 2.3. Analysis of expression of S phase-specific cell cycle regulators in uterine 
stromal cells of C/EBPβ-null mice 
Ovariectomized WT and C/EBPβ-null mice were subjected to artificial decidual 
stimulation. Stromal cell were isolated at different times after application of the stimulus 
and total RNA was prepared from these cells. Five WT or C/EBPβ-null mice were used 
at each time point and the uteri of each category were pooled. The expression levels of 
mRNAs corresponding to cyclin D3, cyclin E1, Cdk2, Cdk4 and cdc25A were monitored 
by real time PCR, using gene-specific primers. All PCR data were normalized with 
respect to the mRNA level of 36B4. The relative fold inductions of the expression of 
these genes at different times were determined after setting that of 0 h WT cells at 1.0. 
The values represent average +/- S.D of three separate measurements. WT: black bar and 
C/EBPβ-null: grey bar.  
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Figure 2.4 C/EBPβ  controls the expression of the cell cycle regulators at G2-M phase. 
Uterine stromal cells were isolated from WT and C/EBPβ-null mice at different times 
after application of artificial decidualization stimulus.  
A-D. Five WT or C/EBPβ-null mice were used at each time point and the uteri of each 
category were pooled. The expression levels of mRNAs corresponding to cyclin A, Cdk1, 
cyclin B1 and cyclin B2 were monitored by real time PCR, using gene-specific primers. 
All PCR data were normalized with respect to the mRNA level of 36B4. The relative fold 
inductions of the expression of these genes at different times were determined after 
setting that of 0 h WT cells at 1.0. The values represent average +/- S.D of three separate 
measurements. WT: black bar and C/EBPβ-null: grey bar. * indicates statistically 
significant change  (P<0.05). 
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E. Stromal cells were isolated from WT or C/EBPβ-null uteri collected at 16 and 20 h 
after artificial decidual stimulation. The cells were lysed, analyzed by SDS-PAGE and  
Fig. 2.4 (continued) C/EBPβ  controls the expression of the cell cycle regulators at 
G2-M phase. Uterine stromal cells were isolated from WT and C/EBPβ-null mice at 
different times after application of artificial decidualization stimulus 
subjected to Western blotting using antibodies directed against cyclin B2 and cyclin A. 
Immunostaining of calnexin served as a loading control.  
F. Stromal cells were isolated from WT or C/EBPβ-null uteri collected immediately after 
artificial decidual stimulation, and allowed to attach to slides for 2 h. The cells were 
cultured in vitro in medium supplemented with P (1 µM) and E (10 nM). At 20 h, the 
cells were fixed and subjected to immunocytochemical staining using a cyclin B2 
antibody. 
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Figure 2.5 Regulation of cyclin B2 expression by C/EBPβ .  
A. Stromal cells were isolated from WT uteri collected immediately after artificial 
decidual stimulation, and allowed to attach to slides for 2 h. The cells were cultured in 
vitro in medium supplemented with P (1 µM) and E (10 nM). At 20 h, the cells were 
treated with formaldehyde, DNA-protein complexes were cross-linked and subjected to 
chromatin immunoprecipitation (ChIP) assay as described in the Materials and methods. 
Chromatin immunoprecipitates obtained using antibodies against RNA polymerase II and 
mouse IgG served as positive and negative controls, respectively. DNAs isolated from the 
immunoprecipitates were used as templates for regular PCR (upper panel) and real time 
PCR (lower panel) using various primer sets to amplify specific regions of the cyclin B2 
promoter. The nucleotide positions of the candidate C/EBP binding sites within the four 
promoter regions analyzed by ChIP are indicated. The experiment was repeated twice and 
representative data are shown.  
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(Fig. 2.5 continued )B. Stromal cells were isolated from WT uteri collected immediately 
after artificial decidual stimulation, and allowed to attach to slides for 2 h. Then the cells 
were transduced with adenovirus expressing dominant-negative A-C/EBP (MOI is 10:1). 
20 h after virus addition, the cells were examined by immunofluorescence using an anti-
HA antibody. 
C. Stromal cells were isolated from WT uteri collected immediately after artificial 
decidual stimulation, and allowed to attach to slides for 2 h. Then the cells were cultured 
in medium supplemented with P (1 µM) and E (10 nM) and transduced with adenovirus 
expressing dominant-negative A-C/EBP or control virus (Ad-GFP) (MOI is 10:1) or no 
virus treated. After 20 h transduction, Cells were treated with formaldehyde and ChIP 
assays were performed as described in the Materials and methods. Chromatin 
immunoprecipitates obtained using antibodies against RNA polymerase II and mouse IgG 
served as positive and negative controls, respectively. DNAs isolated from the 
immunoprecipitates were used as templates for regular PCR (upper panel) and real time 
PCR (lower panel) to determine promoter occupancy by C/EBPβ at the -930 site of the 
Cyclin B2 promoter. The experiment was repeated twice and representative data are 
shown.  
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Figure 2.6 C/EBPβ  regulates the activity of Cdk1.  
A. Ovariectomized WT and C/EBPβ-null mice were subjected to artificial decidual 
stimulation. Stromal cell were isolated at different times after application of the stimulus 
and total RNA was prepared from these cells. Five WT or C/EBPβ-null mice were used 
at each time point and the uteri of each category were pooled. The expression levels of 
Cdk1 mRNAs were monitored by real-time PCR, using gene-specific primers. * indicates 
statistically significant change  (P<0.05). 
B-D. Stromal cells were isolated from WT or C/EBPβ-null uteri collected immediately 
after artificial decidual stimulation, and allowed to attach to slides for 2 h. The cells were 
cultured in vitro in medium supplemented with P (1 µM) and E (10 nM). At 20 h, the 
cells were fixed and subjected to immunocytochemical staining using antibodies against 
Cdk1, cdc25C and phospho-Cdk1 (Thr14/Tyr15).  
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Figure 2.7 Increased expressions of p53, p21 and p27 in C/EBPβ-null uteri 
A-C. Ovariectomized WT and C/EBPβ-null mice were subjected to artificial decidual 
stimulation. Stromal cell were isolated at different times after application of the stimulus 
and total RNA was prepared from these cells. Five WT or C/EBPβ-null mice were used 
at each time point and the uteri of each category were pooled. The expression levels of 
mRNAs corresponding to p53, p21, and p27 were monitored by real time PCR, using 
gene-specific primers. All PCR data were normalized with respect to the mRNA level of 
36B4. The relative fold inductions of the expression of these genes at different times 
were determined after setting that of 0 h WT cells at 1.0. The values represent average +/- 
S.D of three separate measurements. WT: black bar and C/EBPβ-null: grey bar. * 
indicates statistically significant change  (P<0.05). 
D, Stromal cells were isolated from WT or C/EBPβ-null uteri collected at 16 and 20 h 
after artificial decidual stimulation. The cells were lysed, analyzed by SDS-PAGE and  
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Fig. 2.7 (continued) Increased expressions of p53, p21 and p27 in C/EBPβ-null uteri  
subjected to Western blotting using antibodies directed against p53, p21, p27. Calnexin 
immunostaining served as a loading control.  
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Figure 2.8 A schematic of the mechanisms underlying C/EBPβ  regulation of 
endometrial stromal proliferation during decidualization 
C/EBPβ plays a central role in stromal proliferation during decidualization by controlling 
the expression of multiple cell cycle regulatory molecules, such as cyclin B, phosphatase 
cdc25C, and the inhibitory factors p53, p21 and p27, during G2-M transition of the cell 
cycle. CAK is a kinase that induces activating phosphorylation in Cdk1. Wee1 and Myt1 
are kinases that induce inhibitory phosphorylations in Cdk1.  
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CHAPTER 3 
The CCAAT/Enhancer Binding Protein Beta (C/EBPβ) is a Critical Regulator of 
Human Endometrial Stromal Proliferation and Decidualization 
3.1 Abstract 
The human endometrium is a dynamic tissue that shows remarkable changes in 
growth, differentiation and shedding during each menstrual cycle. The sequential actions 
of ovarian steroids estrogen (E) and progesterone (P) during the cycle induce a unique 
process known as pre-decidualization, which involves endometrial stromal proliferation, 
differentiation and remodeling. The molecular pathways underlying this hormonally 
induced cellular transformation event, which is a prerequisite for successful embryonic 
implantation, remain poorly understood. We have recently identified C/EBPβ, a CCAAT 
box-binding transcription factor, as a unique regulator of stromal proliferation and 
decidualization during implantation in mice. To reveal the role of this transcription factor 
in regulating human endometrial stromal cell (HESC) proliferation, we attenuated the 
expression of C/EBPβ via siRNA strategy in primary HESCs synchronized at G1/S 
boundary. Our results suggested that C/EBPβ controls the G1-S phase transition by 
regulating the expression of cyclin E and E2F1, which are critical regulators of DNA 
replication. Using a well-established in vitro system in which primary HESCs undergo 
decidualization upon addition of E, P, and a cyclic AMP analog, we have also addressed 
the role of C/EBPβ in stromal differentiation. Loss of function approaches, involving the 
use of C/EBPβ-specific siRNA or a dominant negative mutant of this transcription factor, 
blocked the decidualization process. In order to identify the molecular pathways 
regulated by C/EBPβ during decidualization, we performed gene expression profiling 
using RNA isolated from normal and C/EBPβ-deficient endometrial stromal cells. Our 
study revealed that several key regulators of stromal differentiation, such as BMP2 and 
Wnt4, IL-11Rα and STAT3, operate downstream of C/EBPβ during decidualization.  
Collectively, our studies uncovered a critical role for C/EBPβ in HESC proliferation and 
differentiation during decidualization.  
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3.2 Introduction 
During each menstrual cycle, lasting about twenty-eight days, the human 
endometrium undergoes cyclical changes including proliferation, differentiation and 
menstruation, which are strictly controlled by the ovarian steroid hormones, estrogen (E) 
and progesterone (P), acting via their cognate receptors. The cycle first proceeds through 
an E-dominated proliferative phase (cycle days 1-14) associated with extensive epithelial 
and stromal regeneration and then enters a P-dominated secretory phase (cycle days 15-
28). During the later phase, maturation and predecidualization of the stromal 
compartment occurs in preparation for embryo implantation (1;2). Predecidualization is a 
process that transforms fibroblast-like endometrial stromal cells into large, rounded, and 
secretory decidual cells. It is initiated in stromal cells surrounding the spiral arteries 
during the mid-late secretory stage of the cycle (2). If pregnancy ensues, a full-blown 
decidualization spreads throughout the stroma under the continued influence of E and P. 
The putative implantation window in the human opens for a short period of time in the 
mid secretory stage of the cycle (cycle days 20-24) (3). Abnormal decidualization of 
endometrial stroma is closely related with recurrent miscarriage and unexplained 
infertility in the human(4;5). A number of recent studies explored steroid hormone 
regulated molecular pathway that operate within the implantation window (6-10).  
However, the identities of the steroid-regulated pathways with defined functions during 
human endometrial stromal proliferation and decidualization process remain largely 
unknown. 
Our previous studies identified C/EBPβ as a novel mediator of the biological 
actions of E and P during early pregnancy (11). This transcription factor belongs to a 
family of basic region/leucine zipper DNA-binding proteins (12), which regulate the 
transcription of target genes by binding to a conserved sequence, known as CCAAT box, 
in their promoter regions. Numerous studies have shown that C/EBPβ is a key regulator 
of proliferation and/or differentiation in multiple tissues, including the ovary, testis, liver, 
adipose tissue, immune system, skin cells and the mammary gland (13-22). Deletion of 
the C/EBPβ gene in the mouse led to female sterility, caused by the inability of the 
mutant mouse to form corpus luteum (13). We have found that the C/EBPβ-null uterus 
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exhibit a complete lack of decidual response to a mechanical stimulus, indicating that this 
transcription factor plays a critical role in regulating the hormone-mediated proliferation 
and differentiation program (11). Analyses of uteri of C/EBPβ-null mice indicated that 
loss of this transcription factor leads to an arrest in stromal cell cycle progression at the 
G2-M boundary. It was revealed that C/EBPβ controls the expression of multiple cell 
cycle regulatory molecules such as B-type cyclins B1 and B2, the phosphatase cdc25c 
and the cell cycle inhibitors p21, p27 and p53, all of which control cdk1 activity critical 
for G2-M transition.  
In this study, we investigated the role of C/EBPβ in HESC proliferation and 
differentiation. In proliferating HESCs, we found that C/EBPβ controls the expression of 
mRNAs encoding several G1-S phase cell cycle molecules, such as cyclin E and E2F1. It 
also controls the activation of Cdk2 by governing the translocation of cyclin E into the 
nucleus. Lack of Cdk2 activity prevents the phosphorylation of Rb and the activation of 
E2F1, leading to a block in DNA replication. We have also used an in vitro stromal 
differentiation system to investigate the role of C/EBPβ in decidualization. Loss-of-
function approaches, using a dominant-negative mutant of C/EBPβ or siRNA targeted 
against its mRNA, indicated that the differentiation process is strongly inhibited in the 
absence of this transcription factor. Using gene expression profiling, we uncovered 
several signaling pathways that operate downstream of C/EBPβ in HESCs during 
decidualization. These pathways included BMP2, Wnt4, IL-11Rα and STAT3, which 
were shown previously to be critical for decidualization in the mouse. C/EBPβ, therefore, 
controls HESC differentiation by regulating the expression of key signaling molecules 
that are conserved between the mouse and the human. 
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3.3 Materials and Methods 
Primary HESC culture, synchronization and in vitro decidualization  
The HESCs were provided by Dr. Robert Taylor (Emory University Medical 
School). These cells were isolated from biopsies taken from the proliferative stage 
endometria of normal cycling women and cultured in DMEM/F-12 (Invitrogen) 
containing 5% (v/v) fetal bovine serum (Hyclone), 50 µg/ml penicillin, and 50 µg/ml 
streptomycin (Invitrogen).  Synchronization of HESCs in G1 phase was achieved by two 
consecutive rounds of thymidine block. Briefly, HESCs were cultured to 60% confluence 
in DMEM/F12-5% FBS and exposed to 2 mM thymidine for 12 h. Cells were then 
washed three times with PBS and the thymidine block was released by culturing the cells 
in fresh DMEM/F12-5% FBS for 12 h.  The cells were subjected to a second round of 
thymidine block in the presence of DMEM/F12-5% FBS containing 2 mM thymidine for 
12 h. Finally, the block was released by washing the cells with PBS, and placing them in 
fresh DMEM/F12-5% FBS. At this time (indicated as time zero), the cells were 
synchronized in G1 phase and poised to progress through the cell cycle in the presence of 
fresh medium. To induce in vitro decidualization, the cells were treated with medium, 
containing 1 µM progesterone (Sigma), 10 nM 17ß-estradiol (Sigma) and 0.5 mM 8-
bromo-adenosine-3', 5'-cyclic monophosphate (8-Br-cAMP) (Sigma). The medium was 
changed every 48 h and the culture was maintained up to 10 days. 
siRNA transfection  
The HESCs were transfected with siRNA against C/EBPβ or scrambled siRNA as 
control (Ambion) following the manufacturer’s protocol. Briefly, SilentFect transfection 
reagent (Bio-Rad Laboratories) was mixed with 40 nM of siRNA and added to HESCs at 
80% confluency. After 24-48h, siRNA was removed and cells were treated with media 
containing E, P, and cAMP to induce decidualization. Cells were harvested at various 
time points following the hormone treatment. Gene expression was examined by 
quantitative real-time PCR using gene-specific primers.  
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Immunocytochemistry  
HESCs were fixed in formalin solution (Sigma) at room temperature for 10 min 
followed by washing with PBS for 10 min. The cells were permeabilized by 0.25% Triton 
X-100 in PBS for 10 min and non-specific binding of antibodies was blocked with 10% 
donkey serum for 1 h at room temperature. Primary antibodies included anti-C/EBPβ (C-
19, Santa Cruz Biotech), anti-cyclin D1 (Santa Cruz Biotech), anti-E2F1 (AbCam) , anti-
Cyclin E (AbCam ), anti-phospho-Rb (Ser-780, Santa Cruz Biotech), anti-phospho-Cdk2 
(T-160, Abcam), and anti-STAT3 (C-20, Santa Cruz Biotech). Incubation with these 
antibodies was performed overnight at 4°C. Fluorescence (Cy3 or Delight 488)-
conjugated anti-mouse IgG or anti-rabbit IgG (Jackson Lab) was used as secondary 
antibody. DAPI (1ug/ml in PBS) was used as counter staining.  
Adenovirus-mediated expression of dominant negative C/EBPβ   
An adenoviral vector expressing a dominant negative mutant of C/EBPβ (A-
C/EBP) was provided by Dr. Charles Vinson (NCI/NIH). This vector expresses A-C/EBP 
under the control of CMV promoter. The protein is expressed with a HA epitope tag. An 
adenoviral vector lacking the A-C/EBP insert was used as a control. Control or A-C/EBP-
carrying adenovirus was added to HESC monolayer (MOI: 10:1) at 80% confluence. 
After 24 h of viral transduction, the viral particles were removed and the cells were 
treated with the hormone cocktail to induce decidualization. 
Quantitative real-time PCR analysis  
Total RNA was extracted from cultured HESCs using the Trizol RNA purification 
kit (Invitrogen) according the manufacture’s instructions. Reverse transcription was 
performed using the cDNA synthesis kit (Invitrogen) following the manufacture’s 
instructions. The expression of C/EBPβ, Rb, E2F1, cyclin E, cdk2, PR, IGFBP-1, PRL, 
BMP2, Wnt4, STAT3, IL-11, and IL-11Rα mRNAs was examined by quantitative real-
time PCR analysis using SYBR-Green super-mix (Bio-Rad Laboratories) and gene-
specific primers. The gene expression level at any given time point or under a given 
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condition was quantified as fold change (mean±SD) relative to that at 0 h or control 
condition after normalization with respect to the internal control 36B4, a gene encoding a 
ribosomal protein. 
Microarray Analysis 
HESCs were obtained from individual biopsies taken from the proliferative stage 
endometria of three different normal cycling women and three separate primary cultures 
were established. These cultures were transfected with control (scrambled) siRNA or 
C/EBPβ-specific siRNA for 24 h and then treated with hormone cocktail (E+P+cAMP) 
with siRNA present for next 24 h. Then siRNAs were removed and incubation with 
hormone cocktail was continued for another 48 h. Cells were harvested and total RNA 
was prepared by TRIzol  Reagent (Invitrogen, CA). RNA integrity was verified using 
Agilent 2100 bioanalyser (Agilent Technologies Inc., Santa Clara, CA, USA) at the 
Biotechnology Center of the University of Illinois, Urbana and Champaign. All RNA 
samples showed an RNA integrity number (RIN) greater than 9.  Each RNA sample was 
processed for microarray hybridization using GeneChip Human Geneme U133 A Plus 
2.0 arrays (Affymetrix Inc., Santa Clara, CA), following the established protocol.  
Quality Control (QC) assessment, data processing and statistical analysis were 
done in R, a software for statistical computing and graphics, using packages from the 
Bioconductor project as indicated. QC assessment showed that all arrays were of 
acceptable quality. The raw, probe-level data were processed with the GCRMA 
algorithm, which performs a GC-based background-correction, does a normalization 
between arrays and summarizes the multiple probes into one probe set value using a 
median polish algorithm. Probe sets that were not called “present” on at least one array or 
“marginal” on at least two arrays using Affymetrix’s Call Detection Algorithm, and did 
not have at least one array with a GCRMA value greater than 2.5, were considered not 
expressed in all samples and were filtered from further analysis. 13,351 probe sets passed 
these filters and were tested for differential expression. The False Discovery Rate 
method8 was used to adjust the p-values, and FDR p-values < 0.05 were considered 
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significantly different. The significantly regulated genes were further sorted by gene 
ontology and pathways using PANTHER Classification Software. 
Statistical Analysis 
The RNA and protein samples were prepared from at least three separate primary 
cultures subjected to the same experimental treatment. The real-time PCR results are 
expressed as mean ± S.D of three separate measurements. Statistical significance of the 
data was determined using one-way ANOVA followed by student t-test. A p-value of 
<0.05 was considered significant. 
3.4 Results 
C/EBPβ-deficient HESCs exhibit impaired proliferation  
During the proliferative phase of the menstrual cycle, HESCs undergo repeated 
cell division to rebuild the functionalis layer of the endometrium.  This proliferative 
activity can be recapitulated in an in vitro primary culture system in which the 
undifferentiated HESCs isolated from proliferative phase of the cycle undergo many 
rounds of cell division when maintained in the presence of serum. We observed that 
when HESCs cultured in a medium containing low (1%) serum are placed in medium 
containing high (5%) serum, there was a significant increase in the rate of proliferation of 
these cells. We observed that the level of C/EBPβ mRNA was markedly elevated within 
12 h of serum addition and the increased expression of this factor was maintained as the 
cells continued to proliferate (Fig. 3.1A). 
To investigate the role of C/EBPβ in HESCs proliferation, we employed a siRNA 
strategy to suppress its mRNA expression. As shown in Figure 1B, we observed that 
transfection of HESCs with C/EBPβ-specific siRNA reduced its mRNA expression ~70% 
within 24 h of treatment. At 48 h following siRNA transfection, there was greater than 
85% reduction in C/EBPβ mRNA levels. Transfection of control (scrambled) siRNA had 
no appreciable effect on C/EBPβ mRNA levels (Fig.3.1B).  Immunocytochemical 
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analysis (Fig. 3.1C) confirmed the drastic reduction in the level of C/EBPβ protein upon 
treatment with C/EBPβ-specific siRNA. 
Our primary cultures consisted of a heterogeneous population of proliferating 
HESCs at various stages of the cell cycle. To synchronize the growth of these cells, we 
subjected them to two consecutive rounds of thymidine block, a well-established method 
of cell synchronization (23). It was shown previously that mammalian cell cycle is 
arrested at the G1 phase when cells are switched to a thymidine-rich (2mM) medium. The 
excess thymidine causes a nucleotide imbalance in the cell, thereby blocking the DNA 
replication and arresting the cell cycle at the late G1 phase prior to its entry into the S 
phase (23). The cells that escaped the first round of thymidine block were subjected to a 
second round of thymidine treatment. To ascertain the efficiency of cell synchronization, 
we monitored BrdU incorporation in these cells before and after the release of the block. 
We added the BrdU to the culture 1 h before the release of 2nd thymidine block or at the 
time of the release of the thymidine block.  
We assessed the BrdU incorporation at different time points by 
immunocytochemistry using anti-BrdU antibody (Fig. 3.2A). No BrdU incorporation was 
detected when it was added prior to the release of the thymidine block, confirming a cell 
cycle arrest prior to the entry into the S phase. When BrdU was added at the time of the 
release of the block, a large number (~70%) of cells entered S phase and exhibited 
substantial BrdU incorporation by 4 h (Fig. 3.2A and 3.2B). By 8 h, more than 80% of 
the cells entered S phase. Collectively, these results indicated the HESCs could be 
effectively synchronized by double thymidine block at G1 –S phase boundary and the S 
phase entry can be easily induced by removing the extra thymidine from the culture.  
We next attenuated the expression of C/EBPβ in synchronized HESCs using 
siRNA targeted to its mRNA. The siRNA was added during the second round of the 
thymidine block and the transfection was carried out for 24 h. The siRNAs were then 
removed and the cells were released from thymidine block to resume their proliferation. 
To monitor the time course of DNA synthesis, BrdU was added to the cultures and its 
incorporation in normal and C/EBPβ-deficient HESCs was monitored by 
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immunocytochemistry (Fig. 3.2C). We observed that the BrdU incorporation was 
markedly reduced in C/EBPβ-deficient HESCs relative to the control cells at 4, 7 and 10 
h following the release of the G1-S arrest (Fig. 3.2C and 3.2D). These results suggested 
that the downregulation of C/EBPβ impairs the entry and progression of HESCs into the 
S phase.  
To further examine the role of C/EBPβ in HESC proliferation, we examined the 
mitotic activity of these cells, using an antibody that recognizes phosphorylated Ser 10 of 
histone 3 (P-His3), a unique mitotic phase marker(24). In proliferating animal cells, the 
P-His3 appears in pericentromeric heterochromatin in late G2 interphase cells and 
spreads throughout the condensing chromatin as mitosis progresses. We observed that the 
control HESCs displayed specific staining of P-His3 by 13 h following the release of 
thymidine block (Fig. 3.3A and 3.3B). The number of P-His-positive cells was increased 
at 16.5 h and the positive staining sustained until 18 h. In contrast, the P-His3 staining 
was drastically reduced in C/EBPβ-deficient HESCs (Fig. 3.3A and 3.3B). These results 
indicated that the majority of the C/EBPβ-deficient HESCs did not undergo the G2-M 
transition, which is presumably a consequence of their G1-S arrest. 
C/EBPβ  regulates the expression and nuclear localization of cyclin E and activated 
phosphorylation of cyclin E-dependent kinase (cdk2) in proliferating HESC 
We next investigated whether C/EBPβ controls the G1-S transition of 
proliferating HESCs by regulating the expression and activation of cyclins and cyclin-
dependent kinases (cdks) that specifically control this checkpoint. We monitored the 
expression of mRNAs corresponding to cyclins D1, E and A, and cdks 2 and 4, which are 
hallmarks of G1 and S phases of the cell cycle. Immunocytochemical studies showed 
comparable cyclin D1 protein expression in HESCs in the presence or absence of 
C/EBPβ (Fig. 3.4A). When we examined the expression of cyclin E in control siRNA-
treated cells, we observed that the mRNA encoding this cyclin is maximally expressed at 
4 h following the release of the thymidine block and its level decreased to basal level by 
8 h. The expression of cyclin E mRNA was markedly reduced in C/EBPβ siRNA-treated 
cells (Fig. 3.4B). No significant alteration was noted in the expression of cyclin A mRNA 
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(Fig. 3.4D). When we monitored cyclin E protein level via immunflorescence, we noted 
robust nuclear staining of this protein in control cells that have entered the S phase  
(Fig. 3.4C). In contrast, in C/EBPβ-deficient cells, the intensity of the nuclear staining of 
cyclin E was strikingly reduced, while more cytoplasm staining was observed in cells 
containing normal levels of C/EBPβ. This altered localization of cyclin E in the C/EBPβ-
deficient cells presumably results from the failure of this cyclin to translocate from 
nucleus to cytoplasm and is likely to contribute to the block in G1-S transition of these 
cells.  
The G1-S arrest could also be a consequence of the loss of activity of cdk2 and 
cdk4, which form active cyclin-cdk complexes with E-type and D-type cyclins, 
respectively. No statistically significant alteration in the expression levels of cdk4 and 
cdk2 mRNAs was observed C/EBPβ-deficient cells compared to the control cells  
(Fig. 3.4E and 3.4F), Since we found the expression and nuclear localization of cyclin E 
is greatly reduced in the absence of C/EBPβ, we examined the activation state of cdk2 in 
these cells. Cdk2 activity requires the recruitment of cyclin E, which triggers a 
phosphorylation at threonine 160 in its activation loop (25). Using an antibody that 
specifically recognizes T160 phosphorylation, we discovered that this activating 
modification of cdk2 was markedly reduced in C/EBPβ-deficient cells compared to 
control cells (Fig. 3.4G). The lack of a functional cyclin E-cdk2 complex likely 
contributes to the G1-S arrest of C/EBPβ-deficient cells.  
C/EBPβ  -mediated pathways control the phosphorylation of Rb and the expression of 
E2F1 in HESC 
The retinoblastoma protein (Rb) is an important inhibitor of cell cycle 
progression. Phosphorylation is the key post-transcriptional modulation controlling its 
function (26). In its hypophosphorylated active form, Rb binds to the E2F family of 
transcription factors, resulting in suppression of their transcriptional activity. In G1 
phase, cyclin D/cdk4 and cyclin E/cdk2 sequentially phosphorylate Rb at T798 and T780, 
respectively(27;28). These modifications produce a hyperphosphorylated Rb, allowing its 
disassociation from E2Fs. This event allows the activation of E2Fs, which then regulate 
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downstream target genes required for entry into S phase (29). To assess whether Rb is 
involved in the G1-S arrest of C/EBPβ-deficient HESCs, we examined its expression 
level and phosphorylation status. We found that the level of Rb mRNA was not 
significantly altered in control- and C/EBPβ siRNA-treated HESCs (Fig. 3.5A). Next, we 
employed an antibody that specifically recognizes the cyclinE/cdk2 phosphorylation site 
of Rb to examine its phosphorylation status. (27;28) Immuncytochemical analysis 
revealed that the phosphorylation of Rb at T780 is markedly reduced in C/EBPβ-deficient 
HESCs (Fig. 3.5B), consistent with the observed lack of cyclin E/cdk2 activity in these 
cells. This finding suggests that hypophosphorylated Rb will remain bound to E2F and 
inhibit its transcriptional activation, which is critical for G1-S transition of the HESCs.  
We also examined whether the expression of the E2F family members is 
controlled by C/EBPβ in HESCs. We noted that the mRNA corresponding to E2F1 is 
prominently expressed in HESCs during the cell cycle (Fig. 3.5C). In contrast, the levels 
of E2F2 and E2F3 mRNAs were relatively low (data not shown). As shown in Figure 5C, 
the level of E2F1 mRNA rose rapidly as the HESCs entered the S phase when the cell 
proliferation is resumed at the end of the thymidine block. This induction in E2F1 gene 
expression was absent in C/EBPβ-deficient cells. This reduction in E2F1 expression was 
further confirmed by examining E2F1 protein levels in control and C/EBPβ-deficient 
HESCs by immunocytochemistry (Fig. 3.5D).  
In vitro decidualization of HESCs; dissection of the proliferation and differentiation 
events  
Our laboratory and others have previously described an in vitro decidualization 
system using primary cultures of HESCs, isolated from proliferative phase human 
endometrium (9;30-33). Addition of a hormone cocktail containing E, P, and a cAMP 
analog to these cultures initiates differentiation of these cells. As shown in Fig. 3.6A, 
within 3-6 days of hormone treatment, the fibroblastic HESCs undergo a striking 
morphological change into plump, epitheloid, decidual cells. This morphological 
transformation was associated with appropriate biochemical changes characteristic of 
decidualization. The expression of mRNAs corresponding to several well-characterized 
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decidual markers, such as PRL, IGFBP-1, and IL-11 was increased within 2-4 days of 
culture and reached a peak by days 6-8 (Fig. 3.6B).  
Since stromal proliferation always precedes stromal differentiation during 
decidualization, it raises an important question: are the proliferation and differentiation 
events connected and interdependent? To address this issue, we first tested whether the 
HESCs are still able to proliferate when the hormone cocktail is added to the cultures to 
initiate differentiation. When we compared the rate of proliferation of HESCs in the 
primary cultures, we found that the cells, which continued to divide and grow robustly in 
the absence of the hormone cocktail, failed to proliferate significantly in the presence of 
the cocktail (Fig. 3.6C). Therefore, it is clear that the initiation of differentiation of the 
stromal cells is accompanied by a cessation of their proliferative activity.  
We next asked whether the proliferation of HESCs is a necessary prerequisite for 
their differentiation. To analyze this issue, we first arrested HESC proliferation by double 
thymidine block and synchronized these cells at G1 phase (Fig. 3.6D). We then added 
hormone cocktail to initiate decidualization of these cells with or without releasing the 
cell cycle block. When the block was released, treatment with hormone cocktail for 72 h 
induced differentiation as evidenced by the enhanced expression of the well known 
decidualization markers: PRL, IGFBP-1 and IL-11. The magnitude of expression of these 
biomarkers was comparable to that seen in an asynchronous culture upon addition of 
hormone cocktail (Fig. 3.6D). Interestingly, we observed that the HESCs, still arrested in 
cell proliferation in the presence of the thymidine block, exhibited a similar robust 
induction of the decidualization markers (Fig. 3.6D), indicating that a block in cell 
proliferation did not prevent stromal decidualization. These results established that we 
have a unique primary culture system in which the differentiation of HESCs can be 
studied independent of cell proliferation. 
C/EBPβ  is an essential regulator of HESC differentiation 
To assess the functional role of C/EBPβ in HESC differentiation, we began by 
monitoring the expression of this factor in the in vitro decidualization system. We 
observed that the expression of C/EBPβ mRNA was significantly enhanced within 12-24 
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h of treatment with hormone cocktail (Fig. 3.7A). This elevated expression of C/EBPβ 
mRNA continued at 48 h. It declined at 72 h but was maintained at a significant level up 
to 9 days of culture. The expression of C/EBPβ protein, monitored by 
immunocytochemistry, also showed significant enhancement at 48 h following treatment 
with hormonal cocktail (Fig. 3.7B). Since the enhanced expression of C/EBPβ occurred 
early (12-24 h) during the decidual program, it raised the possibility that this transcription 
factor is a critical early regulator of this process. 
To test this possibility, we employed a dominant negative mutant to inhibit its 
transcriptional activity and examined the consequences of this intervention on well-
defined differentiation end points. In this mutant, termed A-C/EBP, the basic region 
critical for DNA binding is replaced by acidic amino acids and the transactivation domain 
is deleted producing a molecule that forms stable heterodimers with the leucine zipper 
region of C/EBPβ (34). Expression of A-C/EBP in a cell inhibits endogenous WT 
C/EBPβ by blocking its DNA binding activity and thereby interrupting its transcriptional 
function (34;35). A-C/EBP inhibits the DNA binding of all C/EBP family members but 
not other B-ZIP transcription factors (36). We noted that C/EBPβ is the predominant 
C/EBP family protein that is expressed in HESCs during decidualization (Fig. 3.7C), 
(37). While a robust signal for C/EBPβ mRNA is seen in these cells, very little C/EBPα 
or δ mRNA is detectable during decidualization. These observations suggested that the 
inhibitory action of A-C/EBP in the primary stromal cultures is directed primarily at 
C/EBPβ.  
The expression of A-C/EBP in the adenovirus-transduced HESCs was first 
ascertained by immunocytochemistry using an anti-HA antibody that recognizes the HA-
tagged dominant negative mutant (Fig. 3.7D). A viral vector without the A-C/EBP insert 
was used as a control. Within 24 h of viral transduction, >90% of human stromal cells 
were found to express A-C/EBP. 24 h after virus addition, the cells were treated with the 
hormone cocktail and the culture was continued for 72 h. At that time point, total RNA 
was extracted from cells transduced with control or A-C/EBP virus and expression of 
well-known decidualization markers was monitored. Our results indicated that A-C/EBP 
drastically reduced expressions of PRL, IGFBP-1 and IL-11 mRNAs (Fig. 3.7E). The A-
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C/EBP adenovirus addition had no significant effect on the expression levels of either 
C/EBPβ or PR mRNA (Fig. 3.7E). These results demonstrated that the dominant-negative 
mutant repressed human decidualization and it achieved this presumably by blocking the 
transcriptional activity of the endogenous C/EBPβ. 
To further confirm the functional role of C/EBPβ in human stromal 
differentiation, we employed siRNA strategy to suppress the C/EBPβ mRNA expression 
and then examined its effect on decidualization process by monitoring the expression of 
well-known decidual markers. As shown in Fig. 3.1B and 3.1C, C/EBPβ-specific siRNA 
efficiently reduced the expression of C/EBPβ, both at mRNA and protein level, in 
HESCs. When we investigated the functional consequences of this blockade of C/EBPβ 
expression during stromal differentiation, we observed that siRNA-mediated down-
regulation of C/EBPβ in the HESCs led to a significant reduction in expression of PRL, 
IGFBP-1 and IL-11. In contrast, the level of PR remained mostly unaltered in cells 
treated with either C/EBPβ or control siRNA (Fig. 3.7F). Collectively, these results 
revealed an essential role of C/EBPβ in the stromal differentiation process.  
Identification of the C/EBPβ-regulated gene networks that control human endometrial 
stromal decidualization 
Since C/EBPβ critically controls the differentiation of HESCs in primary cultures, 
we sought to explore the downstream pathways of this transcription factor. Our approach 
involved attenuation of C/EBPβ expression by C/EBPβ-specific siRNA followed by gene 
expression profiling using Affymetrix human GeneChip arrays to identify its downstream 
target genes. Three independent primary HESC cultures were established from biopsies 
derived from three different individuals, and subjected to in vitro decidualization in the 
presence control or C/EBPβ-specific siRNA. Total RNA isolated from these cells was 
used for three sets of microarray analyses. Our study identified many genes whose 
expression was significantly altered in response to C/EBPβ-specific siRNA in all three 
arrays. The expression of 1270 genes was up-regulated and that of 1180 genes was down-
regulated (>1.5 –fold, p-value <0.1) in response to the siRNA intervention. The candidate 
C/EBPβ-regulated genes in the human stromal cells were classified according to their 
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known biological functions by Panther Classification System (Tables 1 and 2). These 
pathways represented a variety of different biological categories, such as regulators of 
proliferation, differentiation, ECM and cytoskeleton structure, inflammation regulation 
and immune function, which are all critical for implantation. 
BMP2/Wnt4 and IL-11 signaling pathways are downstream targets of regulation by 
C/EBPβ  during HESC differentiation 
Among the many genes whose expression was down regulated in response to the 
attenuation of C/EBPβ expression, several biological categories were prominent because 
of their known roles in decidualization (Table 1). One of them represented the TGF beta 
family signaling pathway involving the morphogen BMP2, which is an essential regulator 
of decidualization in both mouse and human (9;38).  Another category that stood out was 
the Wnt signaling pathways such as Wnt4. It is of interest to note that we have 
demonstrated that Wnt4 is a downstream target of BMP2 in both mouse and human 
endometrial stromal cells during decidualization (9). One can, therefore, envision a linear 
pathway involving C/EBPβ, BMP2 and Wnt4, operating during HESC differentiation. 
The other category of C/EBPβ target genes included genes encoding components of the 
IL-11 cytokine pathway, such as IL-11 receptor α and the signal transducer STAT3, 
which are important regulators of decidualization (39-42).  
We confirmed the results of our microarray analysis by performing quantitative 
real-time PCR analysis, using RNA isolated from the HESCs treated with C/EBPβ-
specific or control siRNA. We observed that siRNA targeted to C/EBPβ mRNA 
significantly inhibited the expression of BMP2, Wnt4, IL-11Rα and STAT3 as well as 
that of the classical decidualization markers PRL and IGFBP1 (Fig. 3.8). The 
identification of BMP2, Wnt4, IL-11R α and STAT3, which are known regulators of 
decidualization, as downstream targets of regulation by C/EBPβ supports the central role 
played by this transcription factor in HESC differentiation.  
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3.5 Discussion 
It was shown previously by our laboratory that C/EBPβ mediates steroid-
regulated stromal proliferation and differentiation during implantation in the mouse (11). 
The present study was undertaken to address the role of C/EBPβ in human endometrial 
stromal decidualization. In human endometrium, stromal proliferation occurs mainly in 
the proliferative phase, which precedes stromal differentiation, known as 
predecidualization (43). The post-ovulatory increase of P elevates the intercellular cAMP 
in stromal cells, thereby activating the protein kinase A signaling pathway, which 
contributes to the stromal differentiation process (44). Several factors are known to play 
important roles in controlling human endometrium proliferation or differentiation (6-10). 
Our recent studies described C/EBPβ expression in both epithelial and stromal 
compartments during proliferative and secretory phases of the menstrual cycle (45). An 
intense nuclear expression of C/EBPβ in glandular epithelium and differentiating stroma 
of human endometrium during the mid secretory phase of the cycle (45). These findings 
raised the possibility that C/EBPβ-regulated pathways control HESC function during 
various stages of the menstrual cycle. In the present study, we employed primary cultures 
of endometrial stromal cells isolated from biopsies collected at the proliferative stage of 
the menstrual cycle to demonstrate that C/EBPβ controls HESC proliferation as well as 
differentiation via its downstream signaling pathways. 
Primary HESCs can either proliferate or undergo differentiation, depending on the 
culture conditions. Several laboratories have shown that the HESCs can be maintained in 
proliferating state for many generations or induced to undergo differentiation in response 
to a hormonal cocktail containing P, E, and a cAMP analog (30;43;46-48). This primary 
culture system, therefore, presents a unique opportunity to explore the role of C/EBPβ in 
HESCs proliferation and differentiation. We observed that C/EBPβ expression is 
markedly induced concomitant with stimulation of HESC proliferation by high serum. A 
loss-of-function approach using siRNAs showed that C/EBPβ is a key regulator of the 
G1-S transition during proliferation of HESCs. 
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The mammalian cell cycle proceeds through distinct stages: G1, S, G2, and M 
(49). Progression through each phase of the cell cycle is under the strict control of various 
cyclins, cyclin-dependent kinases (cdks), and other cycle regulatory molecules (49-52) 
The cyclical changes in the expression and localization of cyclins and the sequential 
activation of specific cyclin/cdk complexes drive the cell cycle from one phase to another 
(50). The formation and activation of the cyclin D-cdk4/6 and cyclin E-cdk2 complexes 
are critical for G1-S transition. These complexes participate in the phosphorylation of Rb, 
which critically controls cell cycle progression via its inhibitory association with the E2F 
family of transcription factors (27;28). Hyperphosphorylated Rb dissociates from E2Fs, 
allowing the activation of these transcription factors (26;27;29;53;54). Any interruption 
in the chain of events starting from the activation of D-type or E-type cyclins and their 
target kinases to the eventual activation of E2Fs would result in a G1-S phase block.  Our 
study showed that down regulation of C/EBPβ expression in synchronized HESCs 
inhibits the expression of cyclin E and impairs its nuclear accumulation. This in turn 
prevents cyclin E-dependent phosphorylation and activation of cdk2 function. Lack of 
cdk2 activity prevents phosphorylation on Rb and its dissociation from E2Fs. 
Additionally, E2F1 mRNA and protein expression is diminished in C/EBPβ-deficient 
HESCs. The combination of decreased production of E2F1 and a block in its 
transcriptional activation due to a failure to dissociate from Rb likely contributes to the 
G1-S arrest in the C/EBPβ-deficient cells.  
Recent studies in our laboratory, using a C/EBP-null mouse model, showed that 
despite the loss of C/EBPβ expression, uterine stromal cells are able to enter the S phase 
of the cell cycle and execute DNA synthesis in response to a decidual stimulation (Wei 
Wang, I. C. Bagchi and M. K. Bagchi, unpublished results). The loss of this transcription 
factor did not affect the expression or activity of D-type, A-type or E-type cyclins or their 
target kinases cdk2 and cdk4, which control G1-S transition of uterine stromal cells. The 
C/EBP-null stromal cells, however, were arrested at the G2-M checkpoint of the cell 
cycle. Further analysis revealed that C/EBPβ regulates the expression of several key 
molecules that control G2-M transition. These included cyclins B1 and B2, the 
phosphatase cdc25c, which controls cdk1 activity, and the cell cycle inhibitors p21, p27, 
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p53. These findings are in sharp contrast to our current results in the HESCs that C/EBPβ 
is a key regulator of S phase entry and progression. It is, therefore, evident that the 
C/EBPβ-regulated mechanisms guiding controlling proliferation is not conserved in the 
mouse and the human. 
HESCs undergo limited decidualization, known as predecidualization, during the 
secretory phase of the menstrual cycle (1;2). This unique cellular transformation is an 
essential prerequisite for implantation. In a recent study, we observed intense expression 
of C/EBPβ in the luminal, glandular and stromal cells of the secretory phase 
endometrium (45). A marked increase in nuclear C/EBPβ protein immunostaining was 
seen in stromal cells beginning about cycle day 21, coincident with the start of 
endometrial receptivity. This result is consistent with previous reports, which described 
that C/EBPβ regulates the expression of decidual prolactin, a major marker of 
decidualization of human stromal cells (37;55). In the present study, we analyzed the 
expression of C/EBPβ in a well established in vitro stromal primary culture system in 
which decidualization can be efficiently induced by a hormonal cocktail containing E, P, 
and a cAMP analog (48). The enhanced expression of C/EBPβ occurred early during the 
decidual program, consistent with the hypothesis that it regulates downstream pathways 
critical for this process. Indeed, when we attenuated the transcriptional activity of 
C/EBPβ using a dominant-negative mutant or suppressed its expression by administering 
siRNA targeting its mRNA, the differentiation process was strongly inhibited, providing 
strong evidence that C/EBPβ plays an essential role in human stromal cell 
decidualization. 
Although C/EBPβ is a major regulator of uterine functions in the mouse and the 
human, little is known about its target genes in this tissue. We explored the in vitro 
decidualization system to identify C/EBPβ-regulated downstream pathways during 
stromal differentiation. Using gene expression profiling, we identified as many as 2350 
known genes as potential targets of regulation (both up and down regulated) by C/EBPβ 
during this differentiation process. These genes encoded molecules with a wide range of 
biological functions such as cellular proliferation and differentiation, cellular signaling, 
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regulation of cytoskeleton structure, inflammation and immune regulation, enzyme 
metabolism, transport and ion channel, etc. The identification of large number of 
molecular pathways downstream of C/EBPβ is not unexpected, given the complexity of 
the decidualization process, which involves biological phenomena as varied as 
differentiation, vascular remodeling and maternal immunosuppression. A remarkable 
finding of this study is the discovery that C/EBPβ is the potential regulator of the BMP2-
Wnt4 pathway, which is intimately related with the formation, regulation and function of 
the decidual tissue (9;38). Previous studies established that mice deficient in uterine 
BMP2 are infertile and exhibit a severe defect in stromal differentiation (38). We 
identified Wnt 4 as a downstream target of BMP2 regulation in stromal cells undergoing 
decidualization (9). Attenuation of Wnt 4 expression by siRNAs greatly reduced stromal 
differentiation in vitro, suggesting that it is a candidate mediator of BMP2-induced 
decidualization. It is, therefore, reasonable to conclude that BMP2/Wnt4 pathway 
represents a major avenue via which C/EBPβ exerts its regulatory effects on human 
stromal decidualization.  
C/EBPβ is long known as an acute phase protein in the liver and as a regulator of 
several genes involved in the regulation of inflammatory responses (56). A role for 
C/EBPβ as an inflammation regulator has not been explored in the context of a 
reproductive tissue. The present study revealed that C/EBPβ is a major regulator of 
signaling by the IL-11 cytokine, which is generally anti-inflammatory, during 
decidualization. IL-11 signals via a cell surface receptor complex comprising IL11 
receptor a and the common signaling component gp130, which act through the 
JAK/STAT pathway (57). A number of studies have shown that IL-11 signaling pathway 
is essential for decidualization. In mice, disruption of IL-11Ra expression leads to 
decidualization failure and infertility (39;41). In human endometrium, IL-11 and IL11Ra 
are expressed in decidualizing stromal cells of mid-late secretory-phase, suggesting a 
possible role in this process (58). In human primary stromal cultures, addition of IL-11 
advanced P induced decidualization (59). In vivo immunostaining showed that this 
cytokine is significantly induced in the decidualizing stromal cells in the late secretory 
endometrium (58;60). In recent studies, dysregulation of IL-11-IL11Ra signaling 
 68 
pathway was linked to unexplained female infertility, presumably due to defects in 
decidualization (61-63). Our microarray analysis showed that IL11Ra mRNA expression 
is downstream of C/EBPβ, establishing an important functional link between this 
transcription factor and a local cytokine signal pathway, which is important for biological 
processes leading to the successful establishment of pregnancy. 
In summary, the present study demonstrated that the transcription factor-C/EBPβ 
controls the proliferation and differentiation of HESCs by regulating various target genes. 
This work also indicated that several key regulators of stromal differentiation, such as 
BMP2 and Wnt4, and IL-11Rα and STAT3, operate downstream of C/EBPβ during 
decidualization. Future studies will investigate the mechanisms that govern the regulation 
of these downstream pathways by C/EBPβ.  
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3.7 Figures and legends 
 
Figure 3.1 Down regulation of C/EBPβ   in HESCs  
Primary cultures of HESCs were grown in DMEM/F-12 (1:1) medium containing 1% 
charcoal-stripped FBS for two days.  
A. The cells were harvested at different times after increasing the serum concentration in 
medium to 5% FBS.  Total RNA was isolated and subjected to real time PCR using gene-
specific primers for C/EBPβ. 
B. HESCs were transfected with siRNA (40nM) targeted against C/EBPβ or control 
siRNA (scrambled) as described in the Materials and Method. Total RNA was prepared 
from HESCs at 24 and 48 h after transfection with control or C/EBPβ siRNA and 
subjected to real time PCR using C/EBPβ-specific primers.  
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Fig. 3.1 (continued) Down regulation of C/EBPβ   in HESCs 
C. The expression of C/EBPβ protein was monitored at 72 h after siRNA transfection 
using immunocytochemistry.  
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Figure 3.2 Blockade of G1-S transition in C/EBPβ-deficient HESCs 
A. HESCs were seeded in slide chambers, and synchronized in the G1 phase using a 
double thymidine block as described in the Material and Methods. BrdU was added 1 h 
before or at the time of the second thymidine addition. The cells were fixed in formalin 
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 Fig. 3.2 (continued) Blockade of G1-S transition in C/EBPβ-deficient HESCs  
solution at different times after the second thymidine addition, and then subjected to 
immunocytochemistry using a BrdU antibody. 
B. The percentage of BrdU-positive cells was quantitated at different times after the 
thymidine treatment. Total cell number was estimated by DAPI nuclear staining. Data 
were expressed as average +/- S.D of 5 separate measurements. 
C. HESCs were seeded on slide chambers, synchronized using a double thymidine block, 
and then transfected with siRNA (40nM) targeted against C/EBPβ or control siRNA for 
36 h with thymidine present in the culture. After transfection, cells were washed and 
placed in fresh 5% DMEM/F12 with BrdU added to the culture. Cells were fixed at 
different times after BrdU addition and then subjected to immunocytochemistry using 
anti-BrdU antibody.  
D. The percentage of BrdU-positive cells was quantitated in HESC cultures treated with 
control or C/EBPβ siRNA at different times after BrdU addition. Total cell number was 
estimated by DAPI nuclear staining. Data were expressed as average +/- S.D of five 
separate measurements. * indicates statistically significant change (P<0.05) when 
compared with control siRNA treatment. 
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Figure 3.3 Examination of G2-M phase transition in C/EBPβ-deficient HESCs 
HESCs were seeded on slide chambers, synchronized by double thymidine block, and 
then transfected with siRNA (40nM) targeted against C/EBPβ or control siRNA 
(scrambled) for 36 h with thymidine block in effect. 
 A. After siRNA transfection, cells were washed and cultured in fresh 5% FBS 
DMEM/F12. Cells were fixed at different times and then subjected to 
immunocytochemistry using an anti-phospho-His 3 antibody.  
B. The percentage of phospho-His 3-positive cells was quantitated in HESC cultures 
treated with control or C/EBPβ siRNA at different times after release of the thymidine 
block. Total cell number was estimated by DAPI nuclear staining. Data were expressed 
as average +/- S.D of five separate measurements. * indicates statistically significant 
change (P<0.05) when compared with control siRNA treatment. 
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Figure 3.4 Analysis of expression of G1-S phase regulators in C/EBPβ-deficient 
HESCs 
 75 
Fig. 3.4 (continued) Analysis of expression of G1-S phase regulators in C/EBPβ-
deficient HESCs  
HESCs were synchronized at G1 phase by double thymidine block and then transfected 
with siRNA (40nM) targeted against C/EBPβ or control siRNA (scrambled) for 36 h with 
thymidine present in the culture. Following transfection, cells were washed and placed in 
fresh medium containing 5% FBS and then harvested at different times. The cells were 
fixed and subjected to immunocytochemistry using antibodies against cyclin D1 (A), 
cyclin E (C), and activated form of cdk2 (G). Total RNA was also isolated from these 
cells and the expression of mRNAs corresponding to cyclin E (B), cyclin A (D), Cdk4 
(E), and Cdk2 (F) were monitored by real time PCR, using gene-specific primers. 36B4 
was used as an internal control. The relative expression of these genes at different times 
were determined by normalizing with respect to the level in control siRNA-treated cells 
at 0 h. The values represent mean ± S.D of three separate measurements. * indicates 
statistically significant change (P<0.05) when compared with control siRNA treatment. 
Control siRNA treated: black tower and C/EBPβ siRNA treated: grey tower.  
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Figure 3.5 Impairment of Rb phosphorylation and E2F1 expression in C/EBPβ-
deficient HESCs 
HESCs were synchronized at G1 phase by double thymidine block and then transfected 
with siRNA (40nM) targeted against C/EBPβ or control siRNA (scrambled) for 36 h with 
thymidine present in the culture. Following transfection, cells were washed and placed in 
fresh medium containing 5% FBS and then harvested at different times.  
Panels A and C: Total RNA was isolated from these cells and the expression of mRNAs 
corresponding to Rb (A) and E2F1 (C) was monitored by real time PCR, using gene-
specific primers. 36B4 was used as an internal control. The relative expression of these 
genes at different times was determined by normalizing with respect to the level in 
control siRNA-treated cells at 0 h. The values represent mean ± S.D of three separate 
measurements. * indicates statistically significant change (P<0.05) when compared with 
control siRNA treatment. Control siRNA-treated: black bar and C/EBPβ siRNA-treated: 
grey bar.  
Panels B and D: The cells were fixed and subjected to immunocytochemistry using 
antibodies against pRb (S780) (B) and E2F1 (D). 
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Figure 3.6  In vitro decidualization of HESCs: analysis of proliferation and 
differentiation 
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Fig. 3.6 (continued) In vitro decidualization of HESCs: analysis of proliferation and 
differentiation 
Primary cultures of HESCs were established from endometrial biopsies of normal fertile 
women. The cells were grown in DMEM/F-12 (1:1) medium containing 5% FBS. The 
cells were treated with or without a hormone cocktail containing 0.5mM 8-bromo-cAMP, 
1µM P and 10nM E for 0-11 days. 
A. When the cells were examined morphologically after 6 days of culture, a distinct 
transition from fibroblastic to a plump, epitheloid phenotype, characteristic of decidual 
cells, was observed. 
B. The cells were harvested at different times after addition of hormone cocktail. Total 
RNA was isolated and subjected to real time PCR using gene-specific primers for PRL, 
IGFBP-1, and IL-11. “0h” indicates cells immediately prior to hormone cocktail addition. 
All PCR data were normalized with respect to the mRNA level of 36B4. The relative fold 
change (mean ± SD) at different time points compared to the 0 h control is shown. No 
significant alteration in expression of any of the above genes was noted when cultures 
were maintained in the absence of hormone for 11 days. 
C. HESCs were cultured in DMEM/F12 containing 5% FBS until they reached 50% 
confluency. The cells were treated with or without a hormone cocktail containing 0.5mM 
8-bromo-cAMP, 1µM P and 10nM E for 0-4 days. At different time points, the cells were 
harvested by trypsinization and counted using hemocytometer. The cell numbers were 
determined from three independent plates and mean ± SD are shown.  Untreated: blue 
line, hormone cocktail treated: red line.  
D. HESCs were first synchronized via double thymidine block and then treated with the 
hormone cocktail for 3 days with or without removal of the block. In parallel 
experiments, asynchronous HESCs were treated with hormone cocktail for 3 days. Total 
RNA was isolated from cells under different treatment conditions and the expression of 
decidualization markers, PRL, IGFBP-1 and IL-11 was monitored by real time PCR.  All 
PCR data were normalized with respect to the mRNA level of 36B4. The relative fold 
change (mean ± SD) at different time points compared to respective untreated control is 
shown.  
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Figure 3.7 C/EBPβ  regulates HESC differentiation 
HESCs were treated with a hormone cocktail containing 0.5mM 8-bromo-cAMP, 1µM P 
and 1nM E for 0-9 days.  
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Fig. 3.7 (continued) C/EBPβ  regulates HESC differentiation 
A. The cells were harvested at different times after addition of hormone cocktail. Total 
RNA was isolated and subjected to real time PCR using gene-specific primers for 
C/EBPβ. 
B. Immunocytochemical staining of C/EBPβ in HESCs at 48 h in the presence or absence 
of hormone cocktail. Nuclear staining of C/EBPβ is observed. 
C, HESCs were treated with hormone cocktail for 3 days. RNA was isolated and the 
expression of C/EBP family members, C/EBPα, C/EBPβ, and C/EBPδ, was analysis by 
real time PCR using gene-specific primers. Relative expression levels are shown with the 
level of C/EBPα taken as 1.  
D. HESCs (at ~80% confluency) were transduced with adenovirus expressing dominant-
negative A-C/EBP at a MOI of 10:1). 24 h after virus addition, the cells were examined 
by immunocytochemistry using an anti-HA antibody. 
E. HESCs were transduced with adenovirus expressing dominant-negative A-C/EBP or 
control adenovirus. Cells were transduced with adenovirus for 24 h prior to the addition 
of a hormonal cocktail containing E, P and cAMP. Cells were harvested at 72 h after 
hormone treatment. Total RNA was isolated and subjected to real time PCR using gene-
specific primers for PR, C/EBPβ, PRL, IGFBP-1 and IL-11. Fold-inductions were 
calculated with respect to the expression levels of these genes in stromal cultures prior to 
hormone cocktail addition. All real time PCR data were normalized with respect to the 
mRNA level of 36B4, which encodes a ribosomal protein. * indicates statistically 
significant change (P<0.05) when compared with control (no virus) cells.  
F. HESCs were transfected with siRNA (40nM) targeted against C/EBPβ or control 
(scrambled) siRNA as described in the Materials and Method. 24 h after transfection, 
cells were treated with hormone cocktail and harvested 72 h after treatment. Total RNA 
was isolated and subjected to real time PCR using gene-specific primers for PR, PRL, 
IGFBP-1 and IL-11. Fold-inductions were calculated with respect to the expression levels 
of these genes in stromal cultures prior to the addition of hormone cocktail. Additionally, 
all real time PCR data were normalized with respect to the mRNA level of 36B4. *  
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Fig. 3.7 (continued) C/EBPβ  regulates HESC differentiation 
indicates statistically significant change (P<0.05) when compared with control cells 
subjected to mock transfection. 
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Figure 3.8 C/EBPβ  regulates BMP2/Wnt4 and IL-11 signaling pathways during 
decidualization.  
HESCs were transfected with C/EBPβ-specific or control siRNA (40nM) as described 
above. 24 h after transfection, HESCs were treated with hormone cocktail for 72 h. Total 
RNA was isolated and the expression of PR, C/EBPβ, PRL, IGFBP-1, BMP2, Wnt4, IL-
11Rα and STAT3 was analyzed by real time PCR using gene-specific primers. Relative 
level of gene expression was calculated with respect to the expression levels of these 
genes in cells treated with control siRNA. Additionally, all real time PCR data were 
normalized with respect to the mRNA level of 36B4. * indicates statistically significant 
change (P<0.05) when compared with cells treated with control siRNA.  
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Table 3.1 Signaling pathways down regulated in HESCs in response to C/EBPβ  siRNA  
The microarray data, showing molecular pathways down regulated in response to 
C/EBPβ-specific siRNA, were analyzed by Panther Classification System. REFLIST 
indicates the number of genes in NCBI H. sapiens database that are known to be involved 
in a particular pathway. ComLIST indicates the actual number of genes that are altered in 
this pathway upon siRNA treatment. ComLIST (expected) is the number of genes that are 
predicted to be affected by siRNA treatment. ComLIST (p-value) indicates the statistical 
analysis of the number of genes actually altered in the particular pathway. 
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Table 3.2 Signaling pathways up regulated in HESCs in response to C/EBPβ  siRNA 
The microarray data, showing molecular pathways up regulated in response to C/EBPβ-
specific siRNA, were analyzed by Panther Classification System. REFLIST indicates the 
number of genes in NCBI H. sapiens database that are known to be involved in a 
particular pathway. ComLIST indicates the actual number of genes that are altered in this 
pathway upon siRNA treatment. ComLIST (expected) is the number of genes that are 
predicted to be affected by siRNA treatment. ComLIST (p-value) indicates the statistical 
analysis of the number of genes actually altered in the particular pathway. 
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CHAPTER 4 
Signal Transducer and Activator of Transcription 3 (STAT3) is a Target of C/EBPβ  
and Controls Human Endometrial Stromal Decidualization 
4.1 Abstract 
Our earlier studies revealed that the transcription factor C/EBPβ plays an essential 
role in human endometrial stromal cell (HESC) differentiation. In the present study, we 
undertook the identification of the C/EBPβ-regulated gene networks that control HESC 
differentiation in an in vitro decidualization system. We attenuated C/EBPβ expression 
by siRNA strategy and then performed gene expression profiling, using normal and 
C/EBPβ-deficient HESCs. Our studies revealed that signal transducer and activator of 
transcription 3 (STAT3), which mediates signaling by several cytokines including IL-11, 
is a prominent downstream target of C/EBPβ. Chromatin immunoprecipitation 
experiments indicated that C/EBPβ controls the expression of STAT3 by directly 
interacting with its promoter. siRNA-mediated down regulation of STAT3 expression in 
HESCs resulted in significantly reduced differentiation of these cells, indicating an 
important role for this cytokine signal transducer in the decidualization process. Next, we 
performed gene expression analysis to identify specific genes under STAT3 control 
during HESC differentiation. We found that the expression of the enzyme spingosine 
kinase 1 (SphK1), an important angiogenic and inflammatory factor, is strongly inhibited 
in the absence of STAT3. siRNA-mediated suppression of SphK1 mRNA levels led to a 
block in the HESC differentiation process. This blockade could be reversed upon the 
addiction of spingosine 1 phosphate, the product of SphK1. Collectively, our findings 
provided a novel link between C/EBPβ- and STAT3-dependent cytokine signaling 
pathways that regulate endometrial functions during decidualization. Our study 
uncovered a unique linear pathway involving C/EBPβ, STAT3 and the lipid metabolite 
spingosine 1 phosphate, and indicated that it serves as a regulator of critical biological 
processes during decidualization. 
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4.2 Introduction 
The human endometrium undergoes extensive remodeling during the menstrual 
cycle, which is strictly controlled by the ovarian steroid hormones, estrogen (E) and 
progesterone (P), acting via their cognate receptors. The postovulatory surge of 
progesterone induces sequential morphological and biochemical changes in the stromal 
compartment, which are critical for embryo implantation, and the growth and 
development of fetus during early pregnancy. In the human, this transformation, known 
as pre-decidualization, is initiated around the spiral arteries at mid-late secretory phase 
(cycle day 20-24) and involves the conversion of fibroblast-like stromal cells into large, 
rounded and secretory decidual cell. Following embryo implantation, decidualization 
progresses further, leading to the formation of the pregnancy decidua (1;2).  The 
decidualizing human endometrial stromal cells (HESCs) produce numerous biological 
molecules, including growth factors, cytokines, chemokines, and extracellular matrix 
components, to regulate trophoblast invasion and to attenuate the maternal immune 
response to the fetus (3-6). Impaired decidual progression causes infertility, recurrent 
miscarriages, and disease states such as endometriosis and endometrial cancer (3;7-10).  
To date, development of transgenic mouse models helped to establish functional roles 
of several genes in the decidualization process. These include the progesterone recptor 
A(11), homeobox genes HoxA10 and Hoxa11 (12;13), cycloxygenase 2(14), interleukin 
11 receptor alpha(15), CCAAT/enhancer binding protein beta(16), Indian hedgehog(17), 
steroid receptor coactivator 2(18) etc. Studies employing an in vitro system in which 
HESCs isolated from the proliferative phase of the cycle undergo differentiation in the 
presence of a hormonal cocktail containing E, P and cAMP analog confirmed that several 
genes, such as PR (19) and forehead box O1 (FOXO1)(20), exert important functions 
during the decidualization process in the human.  
Our previous studies have shown that C/EBPβ plays a critical role in human 
endometrial stromal decidualization. We performed gene expression profiling using DNA 
microarrays to identify the downstream pathways regulated by this transcription factor 
during stromal differentiation. Our studies revealed that several key signaling molecules, 
such as BMP2, Wnt4 and VEGFA, operate downstream of C/EBPβ during 
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decidualization. Additionally, the expression of the IL-11 receptor α and its signal 
transducer STAT3 was also markedly reduced upon the attenuation of C/EBPβ 
expression. It is of interest that female mice bearing a null mutation in the gene encoding 
the IL-11 receptor α are infertile due to defective decidualization and improper 
trophoblast invasion (15;21). In the human, IL-11 is maximally expressed during 
decidualization, while its receptor is also present in the decidualizing stromal cell (22). It 
was reported that aberrant production of IL-11 by the endometrium, resulting in 
compromised decidualization, is associated with certain types of infertility (3;9).  
STAT3 is an important signaling mediator for several cytokines, such as IL-6, IL-
11, and leukemia inhibitory factor, which play important roles in immune modulation, 
angiogenesis, and uterine receptivity (23-26). Binding of the cytokines to their specific 
cell surface receptors attracts and activates Janus tyrosine kinases (JAKs), which 
phosphorylate the cytokine receptors, thereby creating active docking sites for STATs. 
Activated STAT3 plays critical roles in angiogenesis and immuno suppression by 
regulating downstream target genes, such as VEGFA (23;27-29).  Earlier studies in the 
mouse indicated that transient blockade of STAT3 expression or function prior to 
implantation significantly reduced the embryo implantation (30;31). In vivo immuno-
localization studies have shown that STAT3 is induced and activated in stromal 
compartment during implantation (26;32;33). Collectively, these results are consistent 
with a potential role of the STAT3 signaling pathway downstream of C/EBPβ during 
human stromal decidualization.  
In this study, we investigated the mechanisms by which STAT3 mediates the 
function of C/EBPβ during HESC decidualization. We observed that the enhanced 
expression of C/EBPβ protein during human endometrial stromal decidualization 
immediately precedes increased activation of STAT3 signaling. Employing a siRNA 
strategy, we confirmed that C/EBPβ regulates STAT3 mRNA and protein expression. 
Our studies using ChIP further revealed that C/EBPβ directly interacts with the STAT3 
promoter to regulate its activity. A loss of function approach using siRNAs demonstrated 
that STAT3 is critical for differentiation of HESCs. Using gene expression profiling, we 
identified STAT3-regulated downstream pathway during stromal differentiation. Our 
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studies showed that SphK1, a key angiogenic and immuno- modulatory molecule, 
operates downstream of STAT3 to control decidualization. Collectively, these studies 
uncovered a unique linear signaling pathway involving C/EBPβ, STAT3, and SphK1, 
which controls decidualization of HESCs and is a likely regulator of angiogenesis and 
immune modulation during early pregnancy.  
4.3 Materials and Methods 
Primary human endometrial stromal culture and in vitro decidualization 
The human endometrial stromal cells (HESCs) were provided by Dr. Robert 
Taylor of Emory University Medical School. These cells were isolated from biopsies 
collected from the proliferative stage endometrium of normal cycling women and 
cultured in DMEM/F-12 medium (Invitrogen) containing 5% (v/v) fetal bovine serum 
(Hyclone), 50 µg/ml penicillin, and 50 µg/ml streptomycin (Invitrogen). To induce 
decidualization, the cells were treated with a hormone cocktail, containing 0.5 mM 8-
bromo-adenosine-3', 5'-cyclic monophosphate (8-Br-cAMP) (Sigma), 1 µM progesterone 
(Sigma) and 10 nM 17ß-estradiol (Sigma). The medium was changed every 48 h and the 
culture was maintained up to 12 days. 
Immunocytochemistry  
HESCs were fixed in formalin solution (Sigma) at room temperature for 10 min 
followed by washing with PBS for 10 min. The cells were permeabilized by 0.25% Triton 
X-100 in PBS for 10 min and non-specific binding of antibodies was blocked with 10% 
donkey serum for 1 h at room temperature. Primary antibodies included anti- C/EBPβ (C-
19, Santa Cruz Biotech), anti-STAT3 (C-20, Santa Cruz Biotech), and anti-phospho-
STAT3 (Ser-727, Cell Signaling Corp.). Incubations with these antibodies were 
performed overnight at 4°C. Fluorescence (Cy3)-conjugated anti-mouse IgG or anti-
rabbit IgG (Jackson Lab) was used as secondary antibody. DAPI (1ug/ml in PBS) was 
used as counter staining 
Adenovirus-mediated expression of dominant negative C/EBPβ   
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An adenoviral vector expressing a dominant negative mutant of C/EBPβ (A-
C/EBP) was provided by Dr. Charles Vinson (NCI/NIH). This vector expresses A-C/EBP 
under the control of CMV promoter. The protein is expressed with a HA epitope tag. An 
adenoviral vector lacking the A-C/EBP insert and expressing GFP was used as a control. 
Control or A-C/EBP-carrying adenovirus was added to HESC monolayer (MOI: 10:1) at 
80%-90% confluency. After 24 h of viral transduction, the viral particles were removed 
and the cells were treated with a hormone cocktail to induce decidualization. 
siRNA transfection  
The HESCs were transfected with siRNA against C/EBPβ, STAT3 or scrambled 
siRNA as control (Silencer select pre-designed, Ambion), following the manufacturer’s 
protocol (Silentfect, Bio-Rad Laboratories). Briefly, SilentFect transfection reagent was 
mixed with 40 nM of siRNA and added to HESCs at 80% confluency. After 24 h, siRNA 
was removed and cells were treated with a hormone cocktail to induce decidualization. 
Cells were harvested after 3 days of hormone cocktail treatment. Gene expression was 
examined by quantitative real-time PCR using gene-specific primers.  
Quantitative real-time PCR analysis  
Total RNA was extracted from cultured HESCs using the TRIzol RNA 
purification kit (Invitrogen), according the manufactures instructions. Reverse 
transcription was performed using the SuperScript Fist-Strand Synthesis System for RT-
PCR (Invitrogen), following the manufactures instructions. The expression of mRNAs 
corresponding to PR, C/EBPβ, IGFBP-1, PRL, STAT3, IL-11, IL-11Rα, SphK1 and 
SphK2 was examined by quantitative real-time PCR analysis using SYBR-Green 
supermix (Bio-Rad Laboratories) and gene-specific primers. The expression level of a 
gene at a given time point or under a certain treatment condition was quantified as a fold 
change (mean±SD) relative to its level at 0 h or untreated condition after normalization 
with respect to the internal control 36B4. 
The primer sets used in real-time PCR experiments are listed below:  
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Gene Sense Primer Anti-sense Primer 
PR TGCCTATCCTGCCTCTCAATCAC CGCCGTCGTAACTTTCGTCTTC 
C/EBPβ AACTCTCTGCTTCTCCCTCTG TGCGTCAGTCCCGTGTAC 
PRL CTACATCCATAACCTCTCCTCAG GGGCTTGCTCCTTGTCTTC 
IGFBP-1 TTATCACAGCAGACAGGTAGG TGGCTTGGCAGGAATGTAG 
IL-11 GCTGCACCTGACAGTTGACT CGCCCCCAGTACTGAAATAA 
IL-11Rα AAGCAGCCGACTATGAGAAC TGTAGGAGGTGAGGTAGCG 
STAT3 ACAGGTGAGGCAGAACAG CCATACGCACAGGAGAGG 
SphK1 CGCTGTGCCTTAGTGTCTAC AGCATAGCCTCCACCTTCTC 
SphK2 ACCTGACTCCTTGCTCCTAC GGTCCTGCTGCTCCTCTG 
PRL assay 
The HESCs were cultured in 6-well plates and decidualization was induced as 
described previously. The culture medium was collected every 48 h and replaced with 
fresh medium. The PRL production was analyzed by an ELISA kit (Cal-Biotech). The 
assay was performed in triplicates, according the manufactures instructions. A quality 
control sample (unused culture medium) was included in each assay. The lower detection 
limit of the assay was 0.3ng/ml of PRL. The inter-assay and intra-assay variability were 
5.8 and 2.3%, respectively.  
Chromatin immunoprecipitation (ChIP) analysis. 
The ChIP analysis was performed using the EZ ChIP (Upstate Biotechnology), 
according to the manufacturer’s protocol. Briefly, HESCs were treated with hormone 
cocktail for 3 days to induce the decidualization. Thereafter, cells (8X106) were placed in 
PBS buffer and cross-linked with 1% formaldehyde for 10 min. The cross-linked cells 
were harvested, lysed using SDS lysis buffer, and sonicated. After pre-clearing the 
lysates with salmon sperm DNA–protein A at 4°C for 2 h, the DNA–protein complexes 
in the supernatant were immunoprecipitated using antibodies against RNA polymerase II, 
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Rabbit IgG (Upstate Biotechnology) or C/EBPβ (c-19, Santa Cruz Biotechnology).  The 
immune complexes were recovered by adding protein A–agarose. The beads were then 
washed repeatedly and the bound complexes were eluted using the elution buffer. The 
cross-linking was reversed and then proteins were digested using 0.5mg/ml proteinase K. 
Purified DNA were used as templates for PCR using various primer sets to amplify 
specific regions of the STAT3 promoter.  
For the experiments using the dominant negative mutant A-C/EBP, HESCs were 
first transduced with control or A/C/EBP adenovirus as described above. After 24 h of 
transduction, the viral particles were removed and the cells were treated with a hormone 
cocktail to induce decidualization. Following 3 days of hormonal cocktail treatment, cells 
were harvested to perform the ChIP assay describe as above.  
Microarray Analysis 
HESCs isolated from proliferative phase endometrial biopsies were transfected 
with scrambled siRNA (control) or STAT3-specific siRNA as described above. 24 h after 
siRNA administration, a hormone cocktail was added to the cells to induce 
decidualization. The decidualization process was allowed to proceed for 3 days following 
the addition of the cocktail. Cells were harvested and total RNA was prepared by TRIzol 
 Reagent (Invitrogen, CA). RNA samples were processed at the Biotechnology Center 
of the University of Illinois, Urbana and Champaign. RNA integrity was verified using 
Agilent 2100 bioanalyser (Agilent Technologies Inc., Santa Clara, CA, USA). Each RNA 
sample was processed for microarray hybridization using Genechip Human Geneme 
U133 A Plus 2.0 arrays (Affymetrix Inc., Santa Clara, CA), following the established 
protocol. The resulting data files were analyzed by Affymetrix GeneChip Command 
Console (AGCC) software. 
Statistical analysis 
The RNA and protein samples were prepared from at least three separate primary 
cultures subjected to the same experimental treatment. The real-time PCR results are 
expressed as mean ± S.D of three separate measurements. Statistical significance of the 
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data was determined using one-way ANOVA followed by student t-test. A p-value of 
<0.05 was considered significant. 
4.4 Results 
Activation of IL-11 signaling pathway during human endometrial stromal 
decidualization 
Our microarray experiments, described in Chapter III, revealed that IL-11 
receptor α is a downstream target of regulation by C/EBPβ in HESCs. This finding raised 
the possibility that this transcription factor controls cytokine signaling pathways that are 
critical for decidualization. Previous studies showed that IL-11 is secreted during cAMP-
induced decidualization of HESCs and addition of recombinant IL-11 to these cells 
enhances their P-induced decidualization in vitro (34). We analyzed the expression 
pattern of IL-11, its receptor IL11Rα, and its signaling transducer STAT3 during human 
stromal decidualization (Fig. 4.1A). Whereas the level of IL-11 mRNA is robustly 
increased during stromal decidualization and reaches a peak by day 5, the level of 
IL11Rα was elevated early in the decidualization program and maintained at a high level 
up to 6 days of culture. The level of STAT3 was enhanced early and reaches a peak by 
day 3 and day 4 and then gradually declines close to basal level.  
In many tissues, cytokines, such as IL11, act through their cell surface receptors 
to activate the signal transducer STAT3 by phosphorylating it initially at Tyr 705, which 
allows it to dimerize and enter the nucleus. This is followed by a phosphorylation at Ser 
727, which activates its transcriptional function and allows it to modulate downstream 
gene expression events (28). We, therefore, examined the temporal pattern of generation 
of activated STAT3 during the in vitro decidualization program by using an antibody that 
specifically recognizes the activating phosphorylation at Ser 727. As shown in Fig. 4.1B, 
coincident with increasing IL-11 production in differentiating stromal cells, 
phosphorylated STAT3 is formed and translocated to the nucleus. The phosphorylated 
state of STAT3 is maintained for several days, although its intensity diminished slightly 
by day 6. These results are consistent with the hypothesis that IL11 signaling pathway 
 98 
may play a functional role in decidualization and its downstream actions might be 
transduced via activation of STAT3.  
STAT3 is a downstream target of C/EBPβ  during decidualization 
As indicated by our microarray analysis described in Chapter III, STAT3 is one of 
the genes, which are significantly repressed upon suppression of C/EBPβ expression in 
HESCs in response to treatment with C/EBPβ-specific siRNA. To confirm the results of 
our microarray analysis, we carried out quantitative real-time PCR analysis, using RNA 
isolated from the HESCs treated with C/EBPβ-specific or control (scrambled) siRNA. 
We observed that treatment with C/EBPβ siRNA, which efficiently down regulated the 
expression of this transcription factor, significantly inhibited the expression of STAT3 as 
well as that of the classical decidualization markers PRL and IGFBP1 (Fig. 4.2A). 
Consistent with the observation that STAT3 mRNA is down regulated in C/EBPβ-
deficient cells, immunocytochemical analyses showed that the cells transfected with 
C/EBPβ siRNA exhibited a drastically decreased STAT3 protein expression, compared 
with the cells transfected with control siRNA (Fig. 4.2B). 
To further confirm this regulatory event, we undertook another loss-of-function 
approach, using a dominant negative mutant of C/EBPβ (A-C/EBP). In this mutant, the 
basic region critical for DNA binding is replaced by acidic amino acids and the 
transactivation domain is deleted, producing a molecule that forms stable heterodimers 
with the leucine zipper region of C/EBPs (35). Expression of A-C/EBP in a cell inhibits 
endogenous WT C/EBPβ by blocking its DNA binding activity and thereby interrupting 
its transcriptional function (35;36).  
In HESCs treated with a “decidualization cocktail” containing P, E, and a cAMP 
analog, the expression of A-C/EBP in the transduced cells had no significant effect on the 
expression levels of either C/EBPβ or PR mRNA (Fig. 4.2C). In contrast, it strongly 
inhibited the expression of mRNAs corresponding to the well-known decidualization 
markers, PRL and IGFBP-1, indicating that the decidualization process is inhibited upon 
the expression of this dominant negative mutant. Our results also indicated that A-C/EBP 
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drastically reduced expressions of STAT3 mRNA. These results clearly demonstrated 
that the dominant-negative mutant repressed human decidualization by specifically 
blocking the transcriptional activity of the endogenous C/EBPβ. STAT3 is, therefore, one 
of the candidate transcriptional targets of C/EBPβ during this differentiation process. 
Direct regulation of STAT3 promoter by C/EBPβ  
To further investigate the mechanism by which C/EBPβ regulates STAT3 
expression, we analyzed its interaction with the promoter of STAT3 gene. In silico 
analysis of the STAT3 promoter using the bioinformatics softwares TESS, TFSearch and 
Consite revealed that it contains four candidate C/EBPβ binding sites within the 2 kilo-
base 5‘-flanking region of the gene at approximately -61, -521, -931 and -1470. To test 
whether C/EBPβ actually binds to one or more of these sites, we employed chromatin 
immunoprecipitation using an antibody specific for C/EBPβ. As shown in Fig. 4.3A, 
minimal binding of C/EBPβ was seen at the –61, -521, and –1470 sites. A relatively 
strong binding of this transcription factor was observed at the STAT3 promoter region -
931.  
To further confirm that this candidate binding region at –931, containing the 
CCAAT motif, is linked to the transcriptional status of the endogenous C/EBPβ, we 
employed the dominant negative mutant A-C/EBP, which inhibits the DNA binding 
ability of C/EBPβ. As shown in Fig. 4.2C, adenovirus-mediated expression of A-C/EBP 
strongly reduced the expression of STAT3 mRNA. When we examined the occupancy of 
the STAT3 promoter by C/EBPβ under these conditions, we found that A-C/EBP 
expression blocked the binding of C/EBPβ to the -931 region of STAT3 promoter  
(Fig. 4.3B). These data suggested that this region of the STAT3 promoter represents a 
major C/EBPβ binding site and likely mediates the direct transcriptional regulation of this 
cytokine signal transducer by C/EBPβ. 
STAT3 controls human endometrial stromal decidualization 
To investigate whether STAT3 plays a regulatory role in the stromal 
differentiation process, we employed siRNA strategy to reduce its expression and then 
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examined the effect of this intervention on decidualization by measuring the expression 
of classical biomarkers of this process. As shown in Fig. 4.4, siRNA-mediated 
attenuation of STAT3 mRNA expression (Fig. 4.4A) and consequent down-regulation of 
STAT3 protein (Fig. 4.4B) led to a marked reduction in the expression of differentiation 
markers, such as PRL and IGFBP-1, but did not significantly affect the mRNA level of 
C/EBPβ and PR (Fig. 4.4A). The reduction of PRL at the protein level was further 
confirmed by ELISA analysis (Fig. 4.4C). These results indicated that C/EBPβ-mediated 
STAT3 expression plays an essential role in human endometrial stromal decidualization.  
Identification of STAT3-regulated gene networks that control HESC differentiation 
Since STAT3 is regulated by C/EBPβ and controls the differentiation of human 
endometrial stromal cell in primary culture, we hypothesized that several C/EBPβ target 
genes will also be regulated by STAT3. To identify these STAT3-regulated genes during 
HESC decidualization, we suppressed its expression by a specific siRNA. The STAT3-
deficient cells were then subjected to decidualization upon addition of the hormone 
cocktail. After 72 h of treatment, we collected total RNA from these cells and compared 
the gene expression profiles of control siRNA-treated and STAT3 siRNA treated HESCs. 
In this microarray analysis, we found that the expression of 759 genes was down 
regulated (>1.5 fold) in response to treatment with STAT3 siRNA. In contrast, the 
expression of 1046 genes was up regulated (>1.5 fold) in response to a similar treatment. 
Further analysis of these microarray-derived genes by Panther classification system 
revealed various molecular pathways that are controlled downstream of STAT3 signaling 
during the HESC decidualization process (Table 1). 
A comparison of the gene expression profile regulated by STAT3 with that 
regulated by C/EBPβ, revealed common pathways that act downstream of both factors. 
Our analysis uncovered 336 genes whose expression was down regulated upon loss of 
C/EBPβ or STAT3 and 457 genes whose expression was up regulated upon loss of 
C/EBPβ or STAT3. The microarray-derived, which are controlled by both C/EBPβ and 
STAT3, are shown in Table 2. 
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SphK1 is a common downstream target of STAT3 and C/EBPβ  during stromal 
differentiation 
A prominent gene whose expression was strongly down regulated in C/EBPβ or 
STAT3-deficient HESCs was that encoding SphK1, a kinase that catalyzes the ATP-
dependent phosphorylation of sphingosine to form sphingosine phosphate (S1P) (Table 
2). To confirm the regulation of SphK1 by STAT3, we attenuated the expression of 
STAT3 mRNA by siRNA followed by treatment with hormone cocktail for three days. 
When the SphK1 mRNA expression was monitored, we found that it was indeed 
drastically reduced in the absence of STAT3 (Fig. 4.5A).  
There are two major sphingosine kinases, SphK1 and SphK2 (37). Next we 
analyzed the temporal expression profiles of these two kinases in differentiating HESCs 
in vitro. Although the expression of SphK2 mRNA was detected in differentiating 
stromal cells, its expression level is much less compared to that of SphK1 (Fig. 4.5B). 
We noted that the expression of Sphk1 mRNA increased as the stromal cells differentiate, 
reached a peak on days 3 and 4, and gradually declined thereafter. The temporal 
expression pattern of SphK1 mRNA, therefore, overlapped closely with that of active 
STAT3 protein, consistent with our finding that SphK1 is a downstream target of STAT3. 
We then investigated whether Sphk1 plays a role in HESC decidualization. We 
employed siRNA strategy to reduce SphK1 mRNA expression and then examined the 
effect of this intervention on decidualization by measuring the expression of classical 
biomarkers (PRL and IGFBP-1) of this process. As shown in Fig. 4.5C, the attenuation of 
SphK1 expression did not significantly affect the mRNA levels of PR and STAT3. In 
contrast, siRNA-mediated inhibition of SphK1 expression led to a marked reduction in 
the expression of PRL and IGFBP-1, as well as VEGF-A, a well-known angiogenic 
factor secreted by differentiating stromal cells.  
To further ascertain that SphK1 controls HESC decidualization, we sought to 
reverse the SphK1 siRNA-mediated inhibition of decidualization by adding back the 
active product of the SphK1 enzyme. In this experiment, we treated the SphK1-defecient 
HESCs with S1P, which is a product of SphK1, to attempt to rescue the inhibition of 
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stromal decidualization. As shown in Fig. 4.5C, addition of S1P to SphK1 siRNA-treated 
stromal cells restored the expression of PRL, IGFBP-1 and VEGF-A mRNAs to levels 
comparable to that seen in control siRNA-treated cells, while this treatment did not 
significantly alter the expression levels of SphK1 and STAT3 mRNAs (Fig. 4.5C). Taken 
together, our results provided strong evidence that SphK1 is an important downstream 
target of STAT3 and a critical regulator of human endometrial stromal decidualization.  
4.5 Discussion 
C/EBPβ is long known as an acute phase protein in the liver and as a regulator of 
several genes involved in the regulation of inflammatory responses (38). A role for 
C/EBPβ as an inflammation regulator has not been explored in the context of a 
reproductive tissue. The present study revealed that C/EBPβ is a major regulator of 
signaling by the IL-11 cytokine, which is generally anti-inflammatory, during 
decidualization. IL-11 signals via a cell surface receptor complex comprising IL11 
receptor α and the common signaling component gp130, and the signal is transmitted 
through the JAK/STAT pathway (39). A number of studies have shown that IL-11 
signaling pathway is essential for decidualization. In mice, disruption of IL-11Rα 
expression leads to decidualization failure and infertility (15;31). In human endometrium, 
IL-11 and IL11Rα are expressed in decidualizing stromal cells of mid-late secretory-
phase, suggesting a possible role in this process (22). In human primary stromal cultures, 
addition of IL-11 advanced P induced decidualization (34). In vivo immunostaining 
showed that this cytokine is significantly induced in the decidualizing stromal cells in the 
late secretory endometrium (22;40). In recent studies, dysregulation of IL-11-IL11Rα 
signaling pathway was linked to unexplained female infertility, presumably due to defects 
in decidualization (3;9;41). Our microarray analysis showed that IL11Rα and STAT3 
mRNA expression are downstream of C/EBPβ, establishing an important functional link 
between this transcription factor and a local cytokine signal pathway, which is important 
for biological processes leading to the successful establishment of pregnancy. 
Although locally produced cytokines facilitate decidualization, little is known 
about the underlying mechanisms by which these factors regulate differentiation (34;42). 
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The cytokines with identified roles in the female reprocuctive tract include the IL-6 
family of cytokines, transforming growth factor beta superfamily, the interleukin 1(IL-1) 
family, and the colony-stimulting factors (CSFs) (43). Dysregulated expression or 
activation of these cytokines was reported to result in complete or partial failure of 
implantation, abnormal placental formation and recurrent miscarriage (6;7;44). Previous 
studies identified STAT3 as a major mediator of signaling by the IL-6 family of 
cytokines, which include IL-6, IL-11 and LIF (28). Our study indicated that primary 
HESCs produce ample amounts of IL-11 during decidualization (Fig. 4.1A), while only 
low amounts of IL-6 and LIF are synthesized in these cells (data not shown). Previous 
studies showed that STAT3 is a key signal transducer that is activated downstream of IL-
11 signaling (45). It was reported that inhibition of STAT3 activation impairs 
implantation in the mouse (31). In our cell culture experiments, the temporal production 
of IL-11 by human stromal cells overlapped with the activation profile of STAT3  
(Fig. 4. 1). Using various loss-of-function approaches, we showed that C/EBPβ regulates 
expression of STAT3. Using a siRNA strategy, we demonstrated that STAT3 expression 
critically controls human stromal decidualization. This conclusion was further 
strengthened via chromatin immunoprecipitation experiments, which revealed that 
C/EBPβ directly binds to the -931 region of the STAT3 promoter that contains a CCAAT 
motif. Expression of a dominant negative mutant A-C/EBP, which blocked DNA binding 
ability of endogenous C/EBPβ, also suppressed the STAT3 promoter occupancy by this 
transcription factor and as a consequence markedly reduced STAT3 mRNA production. 
Taken together, our studies provided convincing evidence that STAT3 is an essential 
mediator of C/EBPβ-driven human endometrial stromal differentiation.  
As a transcriptional regulator, STAT3 is likely to regulate downstream gene 
pathways that help advance the differentiation process. STAT3 is also known to control 
angiogenesis and immunosuppression, biological processes intimately associated with 
decidual functions and embryo survival (23;46). To identify STAT3 target genes during 
stromal differentiation, we employed microarray analysis using HESCs in which STAT3 
expression is attenuated by siRNA. We identified the gene encoding SphK1, a 
sphingosine kinase, as a STAT3-regulated gene. Interestingly, previous microarray 
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results indicated that SphK1 is also downstream of C/EBPβ, suggesting that a linear 
pathway involving C/EBPβ, STAT3 and SphK1 operates during HESC differentiation. 
Sphingosines are lipids, which are implicated in diverse biological functions. The 
S1P and its receptors participate in a key signaling mechanism involved in angiogenesis 
(47), lymphocyte trafficking (48), proliferation, cell survival (37), and 
immunomodulaiton(49). Previous studies have shown that the sphingolipid pathway is 
activated in the decidua and potentially regulates uterine mesometrial angiogenesis 
during implantation (50). Mizugishi et al reported severely compromised fertility in 
SphK1-/-SphK2+/- female mice in which the production S1P is drastically reduced. The 
mutant phenotype was associated with impaired decidualization, infiltration of 
inflammatory cells, increased cell death in the decidua, and massive breakage of decidual 
blood vessels, leading to uterine hemorrhage and early pregnancy loss (51). These results 
underscored the importance of the sphingolipid signaling pathway in decidualization, 
maternal angiogenesis and immune-modulation during early pregnancy.  
In the present study, we observed that SphK1 expression downstream of STAT3 
critically controls human stromal decidualization. Loss of SphK1 expression results in 
impaired decidualization, which is reversed by addition of exogenous S1P. Furthermore, 
we found that SphK1 controls the expression of VEGF-A, a well-known mitogen for 
endothelial cells, thereby suggesting an important functional link between S1P signaling 
and angiogenesis in the human decidua. Therefore, our results in the in vitro 
decualization system are consistent with the findings in the SphK1-/-SphK2+/- female 
mice. It is likely that STAT3, acting directly or indirectly, regulates the expression of 
SphK1, which generates the important lipid metabolite S1P. This signaling molecule in 
turn acts via its receptor to control HESC differentiation. It is conceivable that during 
decidualization, the differentiating stromal cells produce and secrete critical paracrine 
factors, which promote endothelial cell proliferation and control immune cell recruitment, 
thereby regulating angiogenesis and maternal immune response during embryo 
implantation. 
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In summary, C/EBPβ-regulated expression of IL11Rα and STAT3 indicates that 
this signaling pathway plays a vital role during human endometrial stromal 
decidualization. We also found that the expression of SphK1, which generates key lipid 
metabolites, is downstream of both C/EBPβ and STAT3. Our study, therefore, uncovered 
a unique linear pathway involving C/EBPβ, IL-11Rα-STAT3 signaling, and sphingolipid 
signaling, which plays conserved and critical roles in regulating stromal differentiation, 
angiogenesis and immune response during decidualization. 
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4.6 Figures and legends 
 
 
 
Figure 4.1 Activation of IL-11 signaling pathway during decidualization  
HESCs were treated with hormone cocktail to induce decidualization in vitro.  
A. Cells were harvested at different times during the decidualization process. Total RNA 
was isolated from these cells and real time PCR was performed to monitor the expression 
of IL11, IL11Rα and STAT3 mRNAs using gene-specific primers. Fold-changes were 
calculated with respect to the expression levels of these genes in stromal cultures prior to 
hormone cocktail addition (0 h). All real-time PCR data were normalized with respect to 
the mRNA level of 36B4.  
B. The level of phospho-STAT3 (active phosphorylation at Ser 727) was monitored at 
different days of in vitro decidualization by immunocytochemistry using an antibody that 
specifically recognizes the Ser 727 phosphorylated form of STAT3. 
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Figure 4.2  C/EBPβ  controls the expression of STAT3 in differentiating stromal cells 
HESCs were transfected with siRNA (40nM) targeted against C/EBPβ or control siRNA 
(scrambled). 24 h after transfection, HESCs were treated with hormone cocktail to initiate 
the stromal differentiation program in vitro. 
A. Cells were harvested at 72 h following hormone treatment and total RNA was isolated. 
The expression of PR, C/EBPβ, PRL, IGFBP-1 and STAT3 mRNAs was measured by 
real-time PCR analysis using gene-specific primers. The expression of these genes in 
C/EBPβ siRNA treated cells (gray tower) is shown relative to that in control siRNA 
treated cells (black tower, set as 1.0). * indicates statistically significant change (P<0.05) 
when compared with control siRNA treatment. 
B. The expression of C/EBPβ and STAT3 proteins was monitored after 72 h of hormone 
cocktail treatment by immunocytochemistry using antibodies that recognize C/EBPβ and 
STAT3, respectively. 
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Fig. 4.2 (continued) C/EBPβ  controls the expression of STAT3 in differentiating 
stromal cells 
C. HESCs were transduced with adenovirus expressing dominant negative mutant of 
C/EBP (A-C/EBP) or GFP (control)(MOI: 10:1). After 24 h of viral transduction, HESCs 
were treated with hormone cocktail for 72 h. RNA was isolated and the expression of 
C/EBPβ, PR, PRL, IGFBP-1 and STAT3 mRNA was analysis by real-time PCR using 
gene-specific primers.  The mRNA levels were normalized with respect to that in 
untreated (no virus) control. * indicates statistically significant change (P<0.05) when 
compared with no adenovirus treatment. 
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Figure 4.3  Regulation of STAT3 promoter by C/EBPβ  in HESC 
A, HESCs were treated with a hormonal cocktail containing E, P, and cAMP for 72 h. 
Cells were fixed with formaldehyde and ChIP assays were performed using anti- 
C/EBPβ, anti-RNA polymerase II and anti-rabbit IgG antibodies to immunoprecipitate 
the cross-linked DNA-protein complexes. After reversing the cross-links, DNAs isolated 
from the immunoprecipitates were used as templates for PCR using various primer sets to 
amplify specific regions of the STAT3 promoter. The nucleotide positions of the 
candidate C/EBPβ binding sites within the four promoter regions analyzed by ChIP are 
indicated. The experiment was repeated twice and representative data are shown.  
B, HESCs were transduced with adenovirus expressing dominant negative mutant of 
C/EBPβ (A-C/EBP) or Ad-GFP-control (MOI: 10:1). 24 h after viral transduction, 
HESCs were treated with hormone cocktail for 72 h. Cells were treated with 
formaldehyde and ChIP assays were performed to determine promoter occupancy by 
C/EBPβ at the -931 site of the STAT3 promoter. For ChIP experiments, RNA 
Polymerase II (RPII) IP served as a positive control and IgG IP served as a negative 
control. 
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Figure 4.4  Suppression of STAT3 expression blocks HESC decidualization 
HESCs were transfected with siRNA (20nM) targeted against STAT3 or control siRNA 
(scrambled). 24 h after transfection, HESCs were treated with hormone cocktail to initiate 
the stromal differentiation process in vitro.   
A. Cells were harvested at 72 h following hormone treatment and total RNA was isolated. 
The expression of STAT3, C/EBPβ, PR, PRL and IGFBP-1 mRNAs was monitored by 
C/EBPβ siRNA treated cells (gray tower) is shown relative to that in control siRNA 
treated cells (black tower, set as 1.0). * indicates statistically significant change (P<0.05) 
when compared with control siRNA treatment. 
B. The level of STAT3 protein was monitored after 72 h of hormone cocktail treatment 
by immunocytochemistry using an antibody that recognizes total STAT3. 
C. Culture medium was collected at different time points after hormone cocktail 
treatment and the levels of secreted PRL were measured by an ELISA kit. 
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Table 4.1 Pathways regulated by STAT3 during human endometrial stromal 
decidualization 
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Table 4.1 (continued)  Pathways regulated by STAT3 during human endometrial 
stromal decidualization 
A partial list of pathways, whose expression is down (A) and up (B) regulated (>1.5 fold 
change) in response to STAT3 siRNA treatment during HESC differentiation, is shown. 
The microarray data were analyzed using Panther software. REFLIST indicates the 
number of genes in NCBI H. sapiens database that are known to be involved in a 
particular pathway. ComLIST indicates the actual number of genes that are altered in this 
pathway upon siRNA treatment. ComLIST (expected) is the number of genes that are 
predicted to be affected by siRNA treatment. ComLIST (p-value) indicates the statistical 
analysis of the number of genes actually altered in the particular pathway.   
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Table 4.2 Pathways regulated by both C/EBPβ  and STAT3 during human endometrial 
stromal decidualization 
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Table 4.2 (continued) Pathways regulated by both C/EBPβ  and STAT3 during 
human endometrial stromal decidualization 
A partial list of common genes, whose expression are down (A) and up (B) regulated 
(>1.5 fold change) by both C/EBPβ and STAT3 during HESC differentiation, is shown. 
The data were analyzed using Panther software. REFLIST indicates the number of genes 
in NCBI H. sapiens database that are known to be involved in a particular pathway. 
ComLIST indicates the actual number of genes that are altered in this pathway upon 
siRNA treatment. ComLIST (expected) is the number of genes that are predicted to be 
affected by siRNA treatment. ComLIST (p-value) indicates the statistical analysis of the 
number of genes actually altered in the particular pathway 
 
 
 
 
 
 
 
 115 
 
Figure 4.5 SphK1 is a target of STAT3 and controls HESC decidualization 
A. STAT3 controls the expression of SphK1 mRNA during decidualization.  
HESCs were transfected with siRNA (40nM) targeted against STAT3 or control siRNA 
(scrambled). After 24 h transfection, HESCs were treated with hormone cocktail for 72 h 
and the total RNA was isolated. The expression of SphK1 mRNA was monitored by real-
time PCR analysis using gene-specific primers. Fold change was calculated with respect 
to the level of SphK1 mRNA in untreated cells. * indicates statistically significant change 
(P<0.05) when compared with no siRNA treatment. 
B. Temporal expression of SphK1 and SphK2 mRNAs during HESC decidualization in 
vitro. HESCs were treated with hormone cocktail and harvested at different times during 
the decidualization process. Total RNA was isolated and real time PCR was performed to 
monitor the expression of SphK1 and SphK2 mRNAs using gene-specific primers. Fold-
inductions were calculated with respect to the expression levels of these genes in stromal 
cultures prior to hormone cocktail addition (0 h). 
C.  Suppression of SphK1 mRNA expression by siRNA blocks HESC decidualization. 
HESCs were transfected with siRNA (40nM) against Sphk1 or control siRNA. 24h after  
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Fig. 4.5 (continued) SphK1 is a target of STAT3 and controls HESC decidualization 
transfection, the hormone cocktail with or without S1P (5uM/ml) was added to the 
stromal culture. Total RNA was isolated after 72 h and the expression of SphK1, PR, 
STAT3, PRL, IGFBP-1 and VEGF-A were monitored by real time PCR using gene-
specific primers. Fold change was calculated with respect to the expression of these genes 
in cells treated with control siRNA without S1P. *, P<0.05 compared with control siRNA 
treated cells. ,  P<0.05 compared with SphK1 siRNA treated cells. 
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CHAPTER 5  
CONCLUSION 
During early pregnancy, the maternal steroid hormones estrogen and progesterone 
promote - decidualization, a process in which the uterine stromal cells undergo extensive 
proliferation and differentiation and are transformed into decidual cells. This 
physiological event is an essential prerequisite for embryo implantation and its disruption 
leads to dysfunctions in uterine receptivity, resulting in female infertility. However, the 
molecular mechanisms underlying decidualization are not fully understood.  The overall 
objective of my thesis project was to explore the functional role of C/EBPβ, a 
transcription factor, as a unique regulator of decidualization. Using the C/EBPβ-null 
mouse model, we investigated the mechanisms by which C/EBPβ controls stromal 
proliferation during decidualization in the mouse and the human. We discovered that the 
deficiency of this transcription factor leads to a mitotic arrest of the stromal cells in 
mouse. Further studies showed that C/EBPβ controls the stromal cell cycle by governing 
the expression of several key regulatory molecules, including B-type cyclins, cdc25C, 
p53, p21 and p27, which play critical roles in the G2-M transition of the proliferating 
mouse uterine stromal cells. Interestingly, we found that in human endometrial stromal 
cells C/EBPβ controls the G1-S phase transition by regulating the expression of cyclin E 
and E2F1, which are critical regulators of DNA replication.  These findings revealed that 
C/EBPβ controls uterine stromal proliferation in both mouse and human. It exerts this 
effect by regulating the expression of distinct cell cycle factors in a species-specific 
manner and, as a consequence, controls different stromal cell cycle stages in these 
species. 
We employed an in vitro primary culture system to further establish that C/EBPβ 
controls the differentiation of human stromal cells. DNA microarray analyses identified 
the regulatory pathways downstream of this transcription factor that control the 
physiological events during decidualization (Fig. 5.1). It was uncovered that C/EBPβ 
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controls several key components of the cytokine signaling pathway, including the 
cytokine IL11, its receptor and signal transducer-STAT3. Additionally, C/EBPβ was 
noted to control the expression of BMP2 and Wnt4, two important regulators of human 
endometrial stromal differentiation.  
The current challenge is to determine the mechanisms by which C/EBPβ controls 
events, such as angiogenesis and immunosuppression, during decidualization.  Our recent 
studies suggest that C/EBPβ acts through STAT3 to control the expression VEGF-A and 
SphK1, which play key roles in regulating vascular permeability and angiogenesis during 
early pregnancy. Another potential function of C/EBPβ, channeled via activated STAT3, 
is to modulate the maternal immune response. Studies employing DNA microarray 
identified several paracrine factors downstream of STAT3 that might influence the 
conversion of uterine immune progenitor cells into distinct immune cells, reduce their 
cytotoxicity, and promote immuno-suppression to protect the implanted embryo. Further 
exploration of the downstream pathways of C/EBPβ in uterine stromal cells would help 
provide a better understanding of decidualization and implantation, and advance our 
knowledge of the causes underlying unexplained pregnancy loss, thereby improving 
fertility.  
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Figure 5.1 A schematic of the C/EBPβ-regulated pathways that control human 
endometrial stromal cell differentiation, angiogenesis, and immune response during 
decidualization.  
 
 
 
 
 
